{"study_id": 85207, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to review the efficacy of mindfulness-based stress reduction as an adjuvant treatment for psoriasis.", "results_summary": "The study found that mindfulness-based stress reduction can be helpful as an adjuvant treatment for psoriasis, though specific efficacy details were not extensively detailed in the abstract.", "population_specificity": "Patients with psoriasis.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:46:57.144695+00:00"}
{"study_id": 85208, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to examine the existing empirical literature on yoga and its effects on women's health and well-being during the perinatal period, particularly for reducing anxiety and depression.", "results_summary": "Yoga interventions were generally effective in reducing anxiety and depression in pregnant women, showing promise for improving mental health and well-being for women and infants.", "population_specificity": "Pregnant women (perinatal population)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:46:58.227505+00:00"}
{"study_id": 85205, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether cortisol and nausea responses to naltrexone could predict the effectiveness of a mindfulness-based intervention in reducing hedonic eating and weight in obese women.", "results_summary": "The study found that naltrexone-induced cortisol increases were associated with greater hedonic eating and less mindful eating. Mindfulness training led to greater reductions in food addiction symptoms, particularly in participants with larger cortisol increases or nausea responses.", "population_specificity": "Obese women (N=88; age=46.7\u00b113.2 years; BMI=35.8\u00b13.8).", "effective_dosage": "Not specified", "study_duration": "5.5 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:46:58.291683+00:00"}
{"study_id": 85206, "supplement_id": 1338, "safety_score": "90", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether Mindfulness-Based Cognitive Therapy with support to taper or discontinue antidepressants (MBCT-TS) was superior to maintenance antidepressants for preventing depressive relapse or recurrence over 24 months.", "results_summary": "The study found no evidence that MBCT-TS was superior to maintenance antidepressants in preventing depressive relapse, with similar relapse rates and serious adverse events between the two groups. Both treatments showed enduring positive outcomes in relapse prevention, residual symptoms, and quality of life.", "population_specificity": "Adult patients with three or more previous major depressive episodes, on therapeutic doses of maintenance antidepressants, recruited from UK primary care practices.", "effective_dosage": "Not specified", "study_duration": "24 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:46:58.908387+00:00"}
{"study_id": 85209, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to examine interest and participation rates in MBSR training among clinical clerkship students and compare psychological distress, personality traits, and mindfulness skills between interested/non-interested and participating/non-participating students.", "results_summary": "Interest in MBSR was high (53% in Study 1, 72% in Study 2). Students interested in or participating in MBSR reported higher psychological distress, neuroticism, and lower mindfulness skills compared to non-interested/non-participating students.", "population_specificity": "4th-year medical students starting clinical clerkships at Radboud University Medical Center, Nijmegen.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:02.001519+00:00"}
{"study_id": 85210, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of a mindfulness-based stress prevention training (MediMind) for medical students, assessing its impact on stress, coping, psychological morbidity, and personality traits.", "results_summary": "The study protocol outlines a randomized controlled trial design with follow-up assessments, but specific results on mindfulness's effects are not provided in the abstract. The study aims to compare MediMind with Autogenic Training and a control group using validated measures.", "population_specificity": "Medical or dental students in the second or eighth semester at a German university.", "effective_dosage": "Five weekly sessions lasting 90 minutes each.", "study_duration": "5 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:02.203698+00:00"}
{"study_id": 85211, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness of mindfulness-based ERP (MB-ERP) versus standard ERP in reducing OCD symptom severity and improving therapy engagement.", "results_summary": "The study is a pilot trial, so definitive results are not yet available, but it seeks to establish parameters for a future definitive trial to assess whether MB-ERP outperforms ERP in primary and secondary outcomes.", "population_specificity": "40 participants diagnosed with Obsessive Compulsive Disorder (OCD).", "effective_dosage": "10 therapy sessions (frequency not specified).", "study_duration": "Duration of intervention not explicitly stated (implied by 10 sessions).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:05.439574+00:00"}
{"study_id": 85214, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether specific SNPs were associated with cognitive impairment in breast cancer survivors and whether these SNPs moderated cognitive improvements from the MBSR(BC) program.", "results_summary": "SNPs in four genes (ANKK1, APOE, MTHFR, and SLC6A4) were linked to cognitive impairment, and rs1800497 in ANKK1 was significantly associated with cognitive improvement in response to MBSR(BC). These findings suggest MBSR(BC) may be more effective for certain genetic profiles.", "population_specificity": "Breast cancer survivors who completed adjuvant radiation and/or chemotherapy treatment.", "effective_dosage": "Not specified", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:07.317913+00:00"}
{"study_id": 85213, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of a smartphone app-based mindfulness training program for improving smoking cessation rates at 6-months follow-up.", "results_summary": "The study found that smartphone-based mindfulness training showed preliminary efficacy for smoking cessation, with the primary outcome being one-week point prevalence abstinence at 6-months follow-up, validated through carbon monoxide breath monitoring. The intervention provided treatment in real-world contexts to help individuals quit smoking.", "population_specificity": "Daily smokers interested in quitting and owning a smartphone (n=140).", "effective_dosage": "22-day smartphone-based treatment program (frequency not specified).", "study_duration": "22 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:07.348981+00:00"}
{"study_id": 85212, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the feasibility and efficacy of a web-based mindfulness training program combined with phone support for smoking cessation in low socioeconomic status smokers.", "results_summary": "The study found 23.1% and 15.4% smoking abstinence rates at 4 and 6 months post-quit, respectively, along with increased mindfulness and reduced anxiety. The intervention showed reasonable engagement but modest long-term efficacy.", "population_specificity": "Low socioeconomic status smokers (mean age 40.5, smoking 16.31 cigarettes/day for 21.88 years).", "effective_dosage": "Eight weekly video classes (mean completion 5.55 classes), eight weekly phone calls (mean completion 3.19 calls), and 12.17 minutes/day meditation practice.", "study_duration": "8 weeks (with follow-up at 4 and 6 months).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:07.632639+00:00"}
{"study_id": 85215, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to systematically review the effectiveness of MBSR and MBCT in various patient categories by analyzing existing RCTs.", "results_summary": "MBSR and MBCT significantly improved depressive symptoms, anxiety, stress, quality of life, and physical functioning compared to waitlist controls or treatment as usual. Limitations included heterogeneity among patient categories and limited long-term follow-up.", "population_specificity": "Individuals with cancer, cardiovascular disease, chronic pain, depression, anxiety disorders, and healthy adults and children.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:08.243017+00:00"}
{"study_id": 85216, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of mindfulness meditation as an intervention for older adults, focusing on its impact on brain structure and mental health.", "results_summary": "The study found that mindfulness meditation leads to observable changes in brain structure related to memory, self-awareness, empathy, and stress. It suggests mindfulness training can help older adults with depression, anxiety, chronic pain, loneliness, and caregiver burden.", "population_specificity": "Older adults", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:08.943899+00:00"}
{"study_id": 85217, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the feasibility of salivary oxytocin (sOT) as a biological measure and compare the effects of mind-body bridging (MBB) and mindfulness meditation (MM) on sOT levels and health outcomes in cancer survivors with sleep disturbances.", "results_summary": "The study found that sOT levels were stable over time and baseline levels were not correlated with age or sex. MBB showed significantly higher postintervention sOT levels compared to the control (SHE), and both MBB and MM led to greater reductions in sleep problems and improvements in mindfulness and self-compassion.", "population_specificity": "Cancer survivors with self-reported sleep disturbances (n=30).", "effective_dosage": "Interventions were conducted in 3 sessions, once per week for 3 weeks.", "study_duration": "3 weeks (with follow-up at 2 months).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:12.392971+00:00"}
{"study_id": 85220, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether a brief mindfulness practice (Brief-MP) intervention could reduce negative affect, craving, and cigarette use in adult smokers.", "results_summary": "The study found that Brief-MP reduced overall negative affect, craving immediately post-meditation, and cigarettes smoked per day over time compared to the control group.", "population_specificity": "Adult community smokers (N = 44).", "effective_dosage": "20 minutes of meditation daily.", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:14.561824+00:00"}
{"study_id": 85221, "supplement_id": 1338, "safety_score": "100", "efficacy_score": 30, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the benefits and harms of mindfulness compared to usual care for adults with fibromyalgia, focusing on physical functioning, pain, mood, and withdrawals.", "results_summary": "The study found no significant advantage for mindfulness over usual care in improving physical functioning, pain, or mood, with very low to moderate quality evidence. No adverse events were reported.", "population_specificity": "Adults with fibromyalgia, predominantly female, with varying severity of the condition.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:14.967082+00:00"}
{"study_id": 85218, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the feasibility and efficacy of an online group intervention (Cascade) incorporating mindfulness and other cognitive-behavioural coping skills to improve the quality of life of parents of young cancer survivors.", "results_summary": "The study assessed Cascade's impact on parents' quality of life, depression, anxiety, and parenting self-agency, as well as children's quality of life, but specific results regarding mindfulness alone were not detailed in the abstract.", "population_specificity": "Parents (n=120) of children (under 16 years) who completed cancer treatment within the past 1-12 months, recruited from Australian hospitals.", "effective_dosage": "Four weekly 90-minute online group sessions incorporating mindfulness among other skills.", "study_duration": "4 weeks (with follow-ups at 1 and 6 months post-intervention).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:15.646902+00:00"}
{"study_id": 85219, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of DBT-informed skills training, including mindfulness, in reducing symptoms and improving emotion regulation, particularly anger, in patients with borderline personality disorder.", "results_summary": "The study found that DBT-informed skills training significantly reduced symptoms compared to treatment as usual, with increased levels of assertive anger mediating symptom reduction, particularly in social roles, while rejecting anger remained unchanged.", "population_specificity": "Patients with borderline personality disorder (n=41, with 21 in the DBT-informed skills training group and 20 in the treatment as usual group).", "effective_dosage": "Not specified", "study_duration": "20 sessions", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:15.713691+00:00"}
{"study_id": 85222, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the efficacy of cognitive-behavioural interventions, including mindfulness, on outwardly-directed aggressive behaviour in adults with intellectual disabilities.", "results_summary": "One study (n = 34) examined mindfulness-based meditation and found some benefit in improving anger ratings, but the overall evidence was of low quality due to methodological limitations and heterogeneity among studies.", "population_specificity": "Adults with intellectual disabilities exhibiting outwardly-directed aggressive behaviour.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:16.136862+00:00"}
{"study_id": 85223, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the feasibility and potential benefits of a modified mindfulness-based stress reduction (MBSR) program delivered via workshops and teleconferences for kidney transplant candidates.", "results_summary": "The study found high attendance and treatment satisfaction in both groups, with more tMBSR participants expecting significant health benefits. Efficacy outcomes for symptoms and quality of life will be analyzed post-intervention and post-transplantation.", "population_specificity": "Kidney transplant candidates (N = 63).", "effective_dosage": "Standard 8-week MBSR program reconfigured into two in-person workshops and six weekly teleconferences.", "study_duration": "8 weeks (plus follow-up at 6 and 12 months post-transplantation).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:17.876646+00:00"}
{"study_id": 85224, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the effectiveness of mindfulness-based stress reduction (MBSR) for chronic insomnia and combined depressive or anxiety symptoms in adults aged 75 years and over.", "results_summary": "The MBSR group showed significant improvements in sleep quality (PSQI) and depressive symptoms (GDS) with large effect sizes, but no significant change in anxiety symptoms (SAS). The control group showed no significant improvements in any measure.", "population_specificity": "Adults aged 75 years and over with chronic insomnia.", "effective_dosage": "Not specified (eight-week MBSR program).", "study_duration": "Eight weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:21.225524+00:00"}
{"study_id": 85226, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to compare the efficacy of mindfulness and gratitude interventions in reducing depression and stress while increasing happiness levels.", "results_summary": "Both mindfulness and gratitude interventions improved depression, stress, and happiness outcomes over time, unlike the wait-list control group, though efficacy differed between the two interventions.", "population_specificity": "65 women aged 18-46 years (mean age 28.35\u00b16.65 years).", "effective_dosage": "Four times a week for 3 weeks (mindfulness diary and Body Scan meditation).", "study_duration": "3 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:22.832645+00:00"}
{"study_id": 85227, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the benefits of mindfulness-based stress reduction (MBSR) on psychological distress and quality of life among breast cancer survivors.", "results_summary": "MBSR significantly improved psychological domains (depression, anxiety, stress) and overall quality of life in breast cancer survivors compared to the control group. The effects were statistically significant and clinically meaningful.", "population_specificity": "Breast cancer survivors (964 participants across nine studies).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:23.311839+00:00"}
{"study_id": 85228, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the efficacy of acceptance and commitment therapy (ACT) and mindfulness-based interventions for improving outcomes in migraine patients, particularly in reducing headache-related disability and affective distress.", "results_summary": "ACT and mindfulness interventions showed promise in improving functioning and reducing headache-related disability and affective distress in migraine patients, though efficacy is limited by small trials, short follow-up periods, and a need for comparison with established treatments.", "population_specificity": "Migraine patients, particularly those with chronic pain and common comorbidities.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:24.033701+00:00"}
{"study_id": 85230, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to analyze the characteristics, objectives, and outcomes of mindfulness interventions for adolescents, focusing on adaptations made for this group.", "results_summary": "The review found preliminary evidence for mindfulness-based programs in adolescents, but many studies lacked appropriate mindfulness measures or detailed program modifications, making comparisons difficult. Only one clinical randomized controlled trial was identified, indicating nascent but promising research.", "population_specificity": "Adolescents", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:24.129504+00:00"}
{"study_id": 85229, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy, mechanisms of action, and moderators of Mindfulness-Based Stress Reduction (MBSR) for nonclinical populations, focusing on stress and anxiety.", "results_summary": "MBSR showed moderate effectiveness in reducing stress, anxiety, depression, and distress, with small effects on burnout and improvements in quality of life. Effects were maintained at follow-up, but heterogeneity in study designs and outcomes was high.", "population_specificity": "Healthy adults", "effective_dosage": "Not specified", "study_duration": "Average follow-up of 19 weeks (intervention duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:25.019516+00:00"}
{"study_id": 85231, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the feasibility and effectiveness of an online mindfulness-based intervention (ORBIT) for improving quality of life in individuals with late-stage bipolar disorder.", "results_summary": "The study found statistically significant improvements in quality of life for both completers and intent-to-treat samples, with a non-significant trend toward reduced anxiety but no significant changes in depression or stress.", "population_specificity": "Individuals aged 18-65 with a self-reported primary diagnosis of bipolar disorder and six or more episodes, under medical care, with internet access and English proficiency.", "effective_dosage": "Not specified", "study_duration": "3 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:26.522498+00:00"}
{"study_id": 85232, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to examine the effects of daily meditation on pain management in older adults with postherpetic neuralgia.", "results_summary": "The treatment group showed improvement in neuropathic, affective, and total pain scores, while the control group experienced worsening affective pain. Participants adhered well to the meditation and diary requirements.", "population_specificity": "Older adults with postherpetic neuralgia.", "effective_dosage": "Daily meditation (specific duration or type not detailed).", "study_duration": "Six weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:29.062861+00:00"}
{"study_id": 85233, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of an 8-week mindful meditation intervention on respiratory rate and emotional function in people with COPD, and explore breathing timing parameters as a physiological measure of meditation uptake.", "results_summary": "The mindful meditation group showed a significant increase in respiratory rate but a decrease in mindfulness levels compared to controls. Participants who completed six or more classes demonstrated improved emotional function without improved mindfulness.", "population_specificity": "Individuals with chronic obstructive pulmonary disease (COPD)", "effective_dosage": "8-week program (specific frequency not detailed)", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:31.358013+00:00"}
{"study_id": 85236, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of mindfulness-based cognitive therapy (MBCT) in preventing relapse and recurrence in patients with major depressive disorder (MDD).", "results_summary": "MBCT applied to patients in remission was found to protect against subsequent relapse and possibly recurrence, with the largest effects seen in high-risk individuals (e.g., those with unstable remission, more previous episodes, or childhood trauma). Preliminary evidence suggests mediation via changes in cognitive content or processes.", "population_specificity": "Patients with major depressive disorder (MDD) in remission, particularly those at high risk for relapse (e.g., unstable remission, multiple previous episodes, childhood trauma, early onset).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:33.324215+00:00"}
{"study_id": 85234, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the effectiveness and cost-effectiveness of a Skype-delivered mindfulness intervention for reducing distress in people with primary and secondary progressive MS.", "results_summary": "The mindfulness intervention significantly reduced distress, pain, fatigue, anxiety, depression, and impact of MS compared to the control group, with moderate to large effect sizes. There was also an 87.4% probability that the intervention saved on service costs while improving outcomes, though no differences in quality-adjusted life years were observed.", "population_specificity": "People with primary and secondary progressive multiple sclerosis (MS).", "effective_dosage": "Eight-week intervention (specific frequency not detailed).", "study_duration": "Eight weeks, with follow-up at three months post-intervention.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:33.450912+00:00"}
{"study_id": 85235, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of two core mindfulness-meditation components (open monitoring and focused attention) compared to relaxation on subjective, autonomic, and neuropsychological outcomes in a 7.5% CO2 experimental anxiety model.", "results_summary": "Open monitoring (OM) and focused attention (FA) reduced subjective anxiety during CO2 inhalation compared to relaxation, with OM showing a stronger anxiolytic effect. These effects occurred without differences in autonomic arousal or attention measures, supporting mindfulness-meditation's role in emotion regulation during anxiety.", "population_specificity": "32 healthy screened adults", "effective_dosage": "10 minutes of guided practice", "study_duration": "Single session (10-minute intervention, 20-minute CO2 challenge)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:33.518545+00:00"}
{"study_id": 85237, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effect of Mindfulness-Based Stress Reduction (MBSR) on somatic symptoms, distress, mindfulness, and spiritual wellbeing in women with breast cancer, and whether adjuvant therapy or baseline levels of distress, mindfulness, and spiritual wellbeing modified these effects.", "results_summary": "MBSR significantly reduced somatic symptom burden post-intervention and at 6 months, but not at 12 months. It consistently reduced distress at all time points and improved mindfulness at 6 and 12 months, with no significant effect on spiritual wellbeing. No effect modification was identified.", "population_specificity": "336 Danish women operated for breast cancer stages I-III.", "effective_dosage": "Eight-week MBSR program (specific dosage not detailed).", "study_duration": "8 weeks (with follow-ups at 6 and 12 months).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:35.686641+00:00"}
{"study_id": 85238, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to examine moderators of the effects of Mindfulness-Based Cancer Recovery (MBCR) and supportive-expressive therapy (SET) on psychological well-being in breast cancer survivors.", "results_summary": "Participants randomized to their preferred program (MBCR or SET) showed greater improvements in quality of life and spiritual well-being, especially those with higher baseline psychological distress. Program preference and baseline psychological functioning were key predictors of benefits, not personality traits.", "population_specificity": "Distressed stage I-III breast cancer survivors in Canada.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:36.242246+00:00"}
{"study_id": 85239, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether self-reported trait mindfulness reduces spontaneous emotional reactivity during passive viewing of emotional pictures.", "results_summary": "The study found no significant moderating effect of trait mindfulness on emotional responses, with small effect sizes and narrow confidence intervals for most measures. Results did not support the hypothesis that mindfulness reduces spontaneous emotional reactivity.", "population_specificity": "51 participants (specific demographics not detailed).", "effective_dosage": "Not applicable (trait mindfulness, not an intervention).", "study_duration": "Not applicable (single experimental session).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:37.933990+00:00"}
{"study_id": 85240, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the empirical progress in investigating the mechanisms by which mindfulness-based cognitive therapy (MBCT) leads to therapeutic change in recurrent major depressive disorder (MDD).", "results_summary": "The study found that MBCT's effects on recurrent MDD were associated with changes in mindfulness, rumination, worry, compassion, and meta-awareness. Preliminary evidence also suggested roles for attention, memory specificity, self-discrepancy, emotional reactivity, and affect in MBCT's clinical effects.", "population_specificity": "Individuals with recurrent major depressive disorder (MDD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:39.854270+00:00"}
{"study_id": 85242, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare outcomes of meditation interventions in chronic disease patients, focusing on anxiety, depression, and symptom management.", "results_summary": "The review identified 45 studies, with half using clearly defined meditation interventions and half employing randomized control trials. It categorized interventions into seven types based on meditation skills and mindful movement practices.", "population_specificity": "Persons with chronic disease", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:40.893057+00:00"}
{"study_id": 85243, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to systematically review the effects of mindfulness-based interventions for smoking treatment, focusing on cessation, relapse prevention, and coping strategies.", "results_summary": "The review found promising results for mindfulness in smoking cessation, relapse prevention, reducing cigarette consumption, moderating craving effects, and developing coping strategies. Most studies were pilot or feasibility trials with low bias risk in some areas but lacked sufficient data on selection, performance, and detection bias.", "population_specificity": "Tobacco smokers seeking treatment for smoking cessation.", "effective_dosage": "Not specified", "study_duration": "Follow-up periods up to 6 months (exact intervention duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:42.482129+00:00"}
{"study_id": 85241, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to compare the efficacy of Mindfulness-Based Cognitive Therapy (MBCT) versus psycho-education for treating major depression in patients who did not achieve remission after antidepressant treatment.", "results_summary": "MBCT showed greater improvements in depression severity (measured by HAM-D and BDI-II), quality of life, and mindfulness scores compared to psycho-education, particularly over the long-term. The study suggests MBCT's superiority for non-remitted major depression patients, though limited by a small sample size.", "population_specificity": "Adults with major depression who did not achieve remission after at least 8 weeks of antidepressant treatment.", "effective_dosage": "Not specified", "study_duration": "26 weeks (with assessments at baseline, 4, 8, 17, and 26 weeks)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:43.176395+00:00"}
{"study_id": 85244, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the association between hair cortisol concentrations (HCC) and clinical characteristics in patients with structural heart disease, as well as predictors for longitudinal change in HCC following mindfulness training.", "results_summary": "The study found a positive association between HCC and BMI, and that mental health status (mental summary score) and diastolic blood pressure were independent predictors of HCC change over time. Mindfulness training's impact on cortisol levels was indirectly assessed through these associations.", "population_specificity": "261 patients with structural heart disease (mean age: 41.3 years, range 18-65).", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:44.243798+00:00"}
{"study_id": 85245, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of a 5-week mindfulness-based stress management program in reducing stress among medical students in Malaysia.", "results_summary": "The study found significant improvements in mindfulness, perceived stress, mental distress, and self-efficacy one week post-intervention, with sustained higher self-efficacy six months later. Over 90% of participants found the program applicable for helping patients and would recommend it to others.", "population_specificity": "Medical students in Malaysia (N = 75, stratified by years of study).", "effective_dosage": "Not specified (5-week program, frequency not detailed).", "study_duration": "5 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:44.852630+00:00"}
{"study_id": 85246, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to systematically review mediation studies to identify psychological mechanisms underlying MBCT and MBSR's effects on psychological functioning and wellbeing, and evaluate the strength of evidence for each mechanism.", "results_summary": "The study found strong evidence for cognitive and emotional reactivity, moderate evidence for mindfulness, rumination, and worry, and preliminary evidence for self-compassion and psychological flexibility as mechanisms underlying MBIs. TSSEM analysis confirmed mindfulness, rumination, and worry as significant mediators of MBIs' effects on mental health outcomes.", "population_specificity": "Not specified (general review of existing studies)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:46.523819+00:00"}
{"study_id": 85247, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine if mindfulness training combined with traditional health education improves dietary habits and physical activity in adolescents by reducing impulsivity and enhancing planning skills.", "results_summary": "The study will assess feasibility, acceptability, and preliminary efficacy of mindfulness training for promoting healthy behaviors in adolescents, with secondary outcomes including physical activity, diet, impulsivity, mood, BMI, and quality of life. Final results are pending as the study is ongoing.", "population_specificity": "Adolescents (30 students per school) from two schools in central Massachusetts.", "effective_dosage": "Not specified", "study_duration": "2 months (intervention), with follow-up at 8 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:48.456270+00:00"}
{"study_id": 85248, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "To determine the efficacy of mindfulness meditation in improving sleep quality in older adults with moderate sleep disturbances compared to sleep hygiene education.", "results_summary": "Mindfulness meditation significantly improved sleep quality (PSQI scores) compared to sleep hygiene education, with an effect size of 0.89. It also showed benefits for insomnia symptoms, depression, and fatigue, but no significant differences were observed for anxiety, stress, or inflammatory markers (NF-\u03baB).", "population_specificity": "Older adults (mean age 66.3 years) with moderate sleep disturbances (PSQI >5).", "effective_dosage": "6-week intervention (2 hours per week) with assigned homework.", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:49.299043+00:00"}
{"study_id": 85249, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether pre-treatment social anxiety severity moderates the effectiveness of mindfulness-based stress reduction (MBSR) compared to aerobic exercise (AE) for generalized social anxiety disorder.", "results_summary": "Both MBSR and AE produced equivalent reductions in weekly social anxiety symptoms, with MBSR being more effective for lower pre-treatment severity and AE more effective for higher pre-treatment severity. Pre-treatment social anxiety severity was found to moderate treatment outcomes.", "population_specificity": "Individuals with generalized social anxiety disorder.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:49.371293+00:00"}
{"study_id": 85250, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of nonpharmacological interventions, including mindfulness, in improving health outcomes for adults with asthma.", "results_summary": "The study included one mindfulness trial, but the abstract does not provide specific results for mindfulness, only noting that relaxation and CBT showed positive effects on asthma-related quality of life and psychological outcomes.", "population_specificity": "Adults with asthma", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:49.809755+00:00"}
{"study_id": 85253, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 40, "study_goal": "The researchers aimed to evaluate the effectiveness of various treatments, including mindfulness, for sex offenders with intellectual and developmental disabilities (IDD).", "results_summary": "Mindfulness was identified as one of the less common treatments used, but the study found no randomized controlled trials and noted poor overall quality of the studies, complicating conclusions about its efficacy.", "population_specificity": "Sex offenders with intellectual and developmental disabilities (IDD).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:52.271137+00:00"}
{"study_id": 85252, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the association between mindfulness interventions and cortisol levels to determine the efficacy of mindfulness in influencing cortisol.", "results_summary": "The study found inconsistent results regarding mindfulness effects on cortisol, with significant changes observed in within-participant studies but not in randomized controlled trials. Methodological differences and mindfulness pathways were noted as influencing variations in outcomes.", "population_specificity": "Not specified (systematic review of six studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:52.405970+00:00"}
{"study_id": 85251, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore how advanced practice nurses (APNs) can incorporate mindfulness-based stress reduction (MBSR) as a nonpharmacologic tool in clinical practice for health promotion and disease management.", "results_summary": "The study found strong evidence supporting MBSR's effectiveness in improving biological and psychological outcomes across various medical conditions, including acute/chronic pain and hypertension. It highlights MBSR's potential for disease prevention and symptom management.", "population_specificity": "Various patient populations, including those with acute/chronic pain, hypertension, and other medical illnesses.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:52.752876+00:00"}
{"study_id": 85254, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 65, "study_goal": "The researchers aimed to assess the impact of a short-form mindfulness-based stress reduction course on self-reported anxiety, stress, mindfulness, and quality of life in an underserved population.", "results_summary": "The study found statistically significant decreases in anxiety and improvements in health-related quality of life, though mindfulness and stress improvements did not reach statistical significance.", "population_specificity": "23 patients at a federally qualified health center (underserved population).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:53.775752+00:00"}
{"study_id": 85258, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to assess the effectiveness of mindfulness exercises (Qigong) in improving function and global perceived effect in adults with chronic neck pain.", "results_summary": "Mindfulness exercises (Qigong) minimally improved function but did not improve global perceived effect at short-term follow-up. The evidence was part of a broader analysis of various exercise interventions for neck pain.", "population_specificity": "Adults with chronic neck pain, with or without cervicogenic headache or radiculopathy.", "effective_dosage": "Not specified", "study_duration": "Short-term follow-up (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:57.025505+00:00"}
{"study_id": 85255, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of a mindfulness-based stress management program, alone or combined with omega-3 fatty acids, in reducing depression and anxiety symptoms in junior nurses.", "results_summary": "The abstract does not provide specific results on the effectiveness of the mindfulness intervention, as the study appears to be ongoing or results are pending. The primary outcome is the change in HADS scores at 26 weeks, with secondary outcomes including various mental health metrics at 13 and 52 weeks.", "population_specificity": "Junior nurses without managerial positions working in general hospitals in Japan.", "effective_dosage": "The mindfulness intervention consisted of four 30-minute individual sessions.", "study_duration": "The mindfulness sessions were conducted over an unspecified period, but follow-up assessments occurred at 13, 26, and 52 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:58.242062+00:00"}
{"study_id": 85259, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 60, "study_goal": "The researchers aimed to systematically review the characteristics and correlates of individuals who independently choose to practice yoga, including its relationship with psychosocial factors like mindfulness.", "results_summary": "Yoga practice is associated with favorable psychosocial factors such as coping and mindfulness, better subjective health, and health behaviors, but also with more distress and physical impairment. However, the evidence is sparse, and methodological limitations prevent causal inferences.", "population_specificity": "Individuals who independently practice yoga, primarily women and those with higher socioeconomic status.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:58.450108+00:00"}
{"study_id": 85257, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "To determine whether a workplace stress-reduction intervention (mindfulness-based) decreases stress reactivity and burnout risk in highly stressed surgical ICU personnel.", "results_summary": "The intervention significantly reduced salivary \u03b1-amylase (a stress marker) in the treatment group, with no changes in controls. Higher \u03b1-amylase correlated with burnout, suggesting the intervention may reduce both stress reactivity and burnout risk.", "population_specificity": "Surgical intensive care unit personnel", "effective_dosage": "8-week group intervention (mindfulness, gentle yoga, music; frequency not specified)", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:58.482943+00:00"}
{"study_id": 85260, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 45, "study_goal": "The researchers aimed to evaluate the effects of mindfulness training on reducing sitting time at work compared to no intervention or alternative interventions.", "results_summary": "Mindfulness training showed a non-significant reduction in workplace sitting time at six months (-2 minutes) and 12 months (-16 minutes), with low-quality evidence. The effect was inconsistent and not statistically significant.", "population_specificity": "Office workers (257 participants in the mindfulness study).", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:59.458948+00:00"}
{"study_id": 85261, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of two Internet-based mindfulness interventions (basic and HAPA-enhanced) compared to a waitlist control in improving mindfulness and mental well-being.", "results_summary": "The HAPA-enhanced group showed significantly higher mindfulness levels post-intervention, sustained at follow-up. Both mindfulness groups demonstrated improved mental well-being post-intervention, with effects lasting at 3-month follow-up.", "population_specificity": "University students and staff (321 participants).", "effective_dosage": "8-week fully automated online mindfulness training.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:47:59.899721+00:00"}
{"study_id": 85262, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to study the association between dispositional mindfulness and eating behavior in adults with type 1 or 2 diabetes.", "results_summary": "Higher levels of dispositional mindfulness were associated with more restrained eating and less external and emotional eating. The mindfulness subscale 'acting with awareness' was the strongest predictor of reduced external and emotional eating.", "population_specificity": "Adults with type 1 or 2 diabetes (n=634).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:00.871464+00:00"}
{"study_id": 85265, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to present a brain-path activation model to understand individual differences in decision making and psychopathology, with applications including mindfulness.", "results_summary": "The study proposed a model incorporating right hemisphere parallel and left hemisphere serial scanning in decision making, and applied it to clinical mental health, including mindfulness as a tool for positive functioning.", "population_specificity": "Not specified (general clinical mental health applications)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:05.158694+00:00"}
{"study_id": 85264, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the evidence supporting the use of meditation therapies, particularly mindfulness, for treating depressive disorders in non-remitted patients.", "results_summary": "The study found moderate to large reductions in depression symptoms for patients with acute major depressive episodes and residual subacute symptoms, though there was significant heterogeneity in techniques and trial designs. Mindfulness-Based Cognitive Therapy was the most studied approach.", "population_specificity": "Patients with clinically diagnosed depressive disorders, not currently in remission, including those with acute major depressive episodes and residual subacute symptoms.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:05.268955+00:00"}
{"study_id": 85266, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether an 8-week mindfulness-oriented meditation intervention could improve character scores and reduce relapse risk in alcohol-dependent individuals.", "results_summary": "Mindfulness-oriented meditation participants showed increased character scores on the temperament and character inventory and reduced relapse risk compared to the control group. The study supports the therapeutic utility of mindfulness interventions for alcohol dependence.", "population_specificity": "Alcohol-dependent individuals", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:05.826455+00:00"}
{"study_id": 85267, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to examine the efficacy of a 3-week mindfulness protocol delivered via an Android app in reducing stress among adults.", "results_summary": "The study found no significant differences between groups, but both intervention groups (mindfulness and relaxing music) showed improved stress coping and a significant decrease in average heart rate post-session. Both groups also reported moderate but significant perceived stress reduction.", "population_specificity": "56 Italian workers", "effective_dosage": "Not specified", "study_duration": "3 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:06.105726+00:00"}
{"study_id": 85269, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to explore the implementation and effectiveness of brief group cognitive behaviour therapy for psychosis (CBTp) in acute care settings compared to treatment as usual (TAU).", "results_summary": "Participants who received group CBTp showed significantly reduced distress at follow-up and increased confidence compared to TAU, though these effects were not confirmed in intention-to-treat analysis. Qualitative feedback indicated the intervention was acceptable and helpful.", "population_specificity": "Inpatients with psychosis in acute care settings.", "effective_dosage": "Not specified (four-week group CBTp program).", "study_duration": "Four weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:08.296256+00:00"}
{"study_id": 85268, "supplement_id": 1338, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the feasibility, acceptability, and preliminary efficacy of mindfulness-based cognitive therapy for children (MBCT-C) in reducing anxiety symptoms in youth at risk for bipolar disorder.", "results_summary": "Clinician-rated and youth-rated anxiety significantly decreased after the intervention, parent-rated emotion regulation improved, and increases in mindfulness were associated with reduced anxiety. Participants and parents reported high feasibility, acceptability, and usefulness of MBCT-C.", "population_specificity": "10 youth (mean age 13.2; 80% girls; 40% biracial) with generalized, social, and/or separation anxiety disorders and a parent with bipolar disorder.", "effective_dosage": "12 weekly sessions of MBCT-C (specific dosage not quantified).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:08.548752+00:00"}
{"study_id": 85270, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness of a computerized mindfulness-based cognitive therapy intervention (\"Mindfulness in Action\") versus pain management psychoeducation in improving pain-related outcomes and well-being in adults with chronic non-cancer pain.", "results_summary": "Both interventions showed significant improvements in pain interference, acceptance, and catastrophizing, maintained at follow-up. The mindfulness group demonstrated greater benefits in subjective well-being, immediate pain reduction, and emotional/stress management skills, with some effects persisting at follow-up.", "population_specificity": "Adults with chronic non-cancer pain lasting at least 6 months.", "effective_dosage": "Not specified", "study_duration": "Not specified (data collected post-intervention and at 6-month follow-up)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:10.078919+00:00"}
{"study_id": 85263, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to review family intervention studies, including mindfulness practices, to assess their potential for reducing parental stress in families of children with developmental disabilities.", "results_summary": "Mindfulness practices and a peer-mentor model showed promise for effective stress reduction in parents of children with disabilities, though most family studies were descriptive with few intervention trials. Psychoeducational programs and respite care were also found to be beneficial but varied in effectiveness.", "population_specificity": "Parents of children with developmental disabilities, particularly autism and intellectual disabilities.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:10.521059+00:00"}
{"study_id": 85272, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of psychosocial interventions, including mindfulness-based therapy, on psychological and physical health outcomes in patients with chronic obstructive pulmonary disease (COPD).", "results_summary": "Mind-body interventions (e.g., mindfulness-based therapy, yoga, and relaxation) showed a statistically significant effect on physical health outcomes (g = 0.40; CI = 0.01-0.79; p = 0.042). However, the study noted potential publication bias, suggesting cautious interpretation of results.", "population_specificity": "Patients with chronic obstructive pulmonary disease (COPD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:13.391006+00:00"}
{"study_id": 85274, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the potential connections between delay discounting and mindfulness-based approaches in treating addiction.", "results_summary": "The study proposed that mindfulness and distraction techniques may interact with delay discounting in ways that could influence treatment effectiveness, but specific outcomes were not detailed.", "population_specificity": "Individuals with addiction (specific population not further detailed).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:13.437560+00:00"}
{"study_id": 85271, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to examine the empirical evidence regarding the mechanisms through which yoga (including mindfulness) reduces stress.", "results_summary": "The study found that mindfulness, along with positive affect and self-compassion, mediated the relationship between yoga and stress reduction. However, only five studies met the inclusion criteria, indicating limited empirical examination of mechanisms.", "population_specificity": "Not specified (general population with stress-related concerns, inferred from context).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:13.459837+00:00"}
{"study_id": 85273, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether a mindfulness-based SEL program could improve cognitive control, reduce stress, enhance well-being, prosociality, and academic outcomes in elementary school students.", "results_summary": "The SEL program with mindfulness improved cognitive control, stress physiology, empathy, emotional control, optimism, and peer acceptance while reducing depressive symptoms and aggression. It also enhanced school self-concept and prosocial behavior.", "population_specificity": "4th and 5th-grade elementary school students (N = 99).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:14.284812+00:00"}
{"study_id": 85275, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the short-term efficacy of a brief mindfulness-based intervention (MAPS) in reducing stress, depressive symptoms, and inflammatory activity in younger breast cancer survivors.", "results_summary": "The MAPS intervention significantly reduced perceived stress and proinflammatory signaling, with marginal reductions in depressive symptoms. Secondary improvements included reduced fatigue, sleep disturbance, and vasomotor symptoms, though psychological benefits were not sustained at the 3-month follow-up.", "population_specificity": "Premenopausal women (aged \u226450) diagnosed with early-stage breast cancer who had completed treatment.", "effective_dosage": "6-week Mindful Awareness Practices (MAPS) intervention (specific frequency not detailed).", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:16.939511+00:00"}
{"study_id": 85277, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the benefits of mindfulness and acceptance-based treatments (MABTs) for social anxiety disorder (SAD).", "results_summary": "MABTs demonstrated significant improvements in SAD symptomatology, but benefits were equivalent or less than those from cognitive-behavioral therapy (CBT). The findings were limited by methodological weaknesses and small sample sizes.", "population_specificity": "Individuals with social anxiety disorder (SAD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:17.022040+00:00"}
{"study_id": 85276, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to validate the German short form of the Langer Mindfulness Scale (LMS) for measuring mindfulness in German-speaking patients with severe traumatic brain injury (TBI) and their healthy relatives.", "results_summary": "The study reduced the original 21-item LMS to a 6-item unidimensional scale, demonstrating high internal consistency (\u03b1 = 0.82) and good test-retest reliability (intra-class correlation = 0.46). External validity was confirmed for the entire sample, indicating the scale is a valid and reliable measure of mindful creativity.", "population_specificity": "German-speaking patients with severe TBI and their healthy relatives (controls).", "effective_dosage": "Not specified", "study_duration": "6-month intervals for test-retest interviews", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:17.277839+00:00"}
{"study_id": 85278, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effect of an individually tailored biopsychosocial intervention, including mindfulness practice, on musculoskeletal pain, stress, and work disability in lab technicians with chronic pain.", "results_summary": "The study implemented mindfulness as part of a multifactorial intervention to lower or prevent stress development, but specific results on mindfulness alone were not detailed in the abstract. The primary outcome focused on pain intensity reduction.", "population_specificity": "Female laboratory technicians (18-67 years old) with chronic musculoskeletal pain (\u22653 months, \u22653 days/week) in upper back, low back, neck, shoulder, elbow, or hand.", "effective_dosage": "Not specified", "study_duration": "10 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:19.857194+00:00"}
{"study_id": 85281, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the long-term impact of an MBSR program on improving well-being, including relaxation states and positive emotions, in physicians over a one-year period.", "results_summary": "The study found significant improvements in mindfulness, relaxation, and positive emotional states in the intervention group after eight weeks, with further increases in effect sizes after a 10-month maintenance period. Heart rate also significantly decreased and remained lower a year after treatment.", "population_specificity": "42 physicians", "effective_dosage": "8-week MBSR program with a 10-month maintenance period", "study_duration": "1 year (8-week intervention + 10-month maintenance)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:22.068561+00:00"}
{"study_id": 85279, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether app-delivered mindfulness meditation, as part of a relaxation intervention, is more effective than usual care alone in reducing chronic low back pain or neck pain.", "results_summary": "The study design suggests potential efficacy of mindfulness meditation for pain reduction, but specific results are not provided in the abstract; outcomes include pain intensity, pain acceptance, stress, and medication intake over 3 and 6 months.", "population_specificity": "Adults aged 18-65 with chronic (>12 weeks) low back pain or neck pain and average pain intensity \u22654 on a numeric rating scale.", "effective_dosage": "15 minutes/day, at least 5 days/week", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:22.089290+00:00"}
{"study_id": 85282, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the feasibility of a mindfulness-based psychotherapy protocol in a small sample of patients with psychogenic nonepileptic seizures (PNES).", "results_summary": "The study demonstrated that mindfulness-based intervention was feasible in real-life clinical scenarios for 6 PNES patients, warranting further investigation in larger studies. No significant adverse effects were reported, but efficacy was not thoroughly assessed.", "population_specificity": "Patients with psychogenic nonepileptic seizures (PNES).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:22.150675+00:00"}
{"study_id": 85280, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of mindfulness-based cognitive therapy (Project UPLIFT) in preventing major depressive disorder episodes and reducing depressive symptoms in people with epilepsy.", "results_summary": "The intervention significantly reduced the incidence of MDD episodes (0.0% vs. 10.7% in the control group), decreased depressive symptoms, and increased life satisfaction. The effects were mediated by improved knowledge/skills and persisted over a 10-week follow-up.", "population_specificity": "Adults with epilepsy and mild/moderate depressive symptoms from Georgia, Michigan, Texas, and Washington.", "effective_dosage": "8 weekly sessions of group-delivered mindfulness-based cognitive therapy (Web or telephone).", "study_duration": "8 weeks (with follow-up assessments at ~10 and ~20 weeks).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:23.806827+00:00"}
{"study_id": 85283, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness of mindfulness-based cognitive therapy (MBCT) for reducing anxiety symptoms in adults with bipolar spectrum disorders (BPSD).", "results_summary": "The data for MBCT appears equivocal, meaning the results are inconclusive or mixed regarding its effectiveness in reducing anxiety in BPSD.", "population_specificity": "Adults with bipolar spectrum disorders (bipolar I, II, not otherwise specified, cyclothymia, and rapid cycling disorders).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:25.056575+00:00"}
{"study_id": 85284, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of mindfulness-based stress reduction (MBSR), a cognitive behavioral stress-eating intervention (SEI), and their combination on stress-related eating, perceived stress, and weight loss.", "results_summary": "All three interventions significantly reduced perceived stress and stress-eating, with the combination intervention showing greater reductions and a moderate effect on short-term weight loss. Benefits persisted at six-week follow-up, suggesting the combination intervention may be promising for treating stress-related eating.", "population_specificity": "Overweight participants (98% female) with elevated stress and stress-eating, at risk for obesity.", "effective_dosage": "Not specified", "study_duration": "Six weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:26.493254+00:00"}
{"study_id": 85285, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of Mindful Mood Balance (MMB), a web-based delivery of Mindfulness-based Cognitive Therapy (MBCT), in reducing depressive symptoms and improving mindfulness compared to usual depression care.", "results_summary": "MMB significantly reduced depressive severity, rumination, and improved mindfulness, with sustained effects over six months. It showed clinical benefits compared to usual care, though engagement varied, with 42-53% completing all or at least half the sessions.", "population_specificity": "Recurrently depressed individuals, including a subgroup with residual depressive symptoms (RDS).", "effective_dosage": "8 sessions (frequency not specified)", "study_duration": "8 sessions with 6-month follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:27.000415+00:00"}
{"study_id": 85286, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to review the effectiveness of cognitive-behavioral, behavioral, and mindfulness-based (CBBMB) therapies in treating depression during the menopausal transition.", "results_summary": "The review found that CBBMB interventions targeting hot flashes or menopausal symptoms generally had a positive impact on mild depression symptoms, though only two studies specifically evaluated CBBMB for menopausal depression.", "population_specificity": "Women experiencing menopause, particularly those with depression symptoms.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:28.438152+00:00"}
{"study_id": 85289, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine the effect of Mindfulness-Based Cognitive Therapy (MBCT) in reducing depression symptoms in drug-dependent males with co-morbid depression.", "results_summary": "The study found that MBCT significantly decreased depression symptoms in the intervention group compared to the control group, as measured by the BDI-II. The results suggest MBCT is effective for treating depression in this population.", "population_specificity": "Drug-dependent males with co-morbid depression (n=33).", "effective_dosage": "Eight 2-hour sessions of MBCT training.", "study_duration": "Duration of the intervention was not explicitly stated, but it involved eight sessions.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:30.129363+00:00"}
{"study_id": 85288, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to test the efficacy of the SMART program in reducing stress and anxiety while improving resilience and quality of life among Department of Radiology physicians.", "results_summary": "The study found statistically significant improvements in perceived stress, anxiety, quality of life, and mindfulness in the SMART program group compared to the control group, though resilience improvements were not statistically significant.", "population_specificity": "Department of Radiology physicians (n=22 completed the study).", "effective_dosage": "Single 90-minute group session with two follow-up phone calls.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:31.007543+00:00"}
{"study_id": 85287, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate an acceptance-based, self-regulation framework for weight maintenance and its integration into behavioral obesity treatment.", "results_summary": "The study found that acceptance-based interventions were efficacious for weight control, particularly for individuals highly responsive to cues for overeating and sedentary behavior. These interventions emphasized skills like tolerating discomfort, behavioral commitment to values, and metacognitive awareness.", "population_specificity": "Individuals with obesity, particularly those susceptible to eating in response to internal and external cues.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:31.008839+00:00"}
{"study_id": 85290, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness of mindfulness-based group therapy versus treatment as usual (primarily individual-based CBT) for patients with depressive, anxiety, or stress and adjustment disorders.", "results_summary": "Both mindfulness-based group therapy and treatment as usual significantly reduced symptom scores, with no significant differences between the two groups, indicating non-inferiority of mindfulness therapy.", "population_specificity": "Primary care patients aged 20-64 with depressive, anxiety, or stress and adjustment disorders in Southern Sweden.", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:31.400427+00:00"}
{"study_id": 85291, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of Mindfulness-Based Stress Reduction (MBSR) on psychological and physiological functioning in female fibromyalgia patients.", "results_summary": "MBSR significantly reduced perceived stress, sleep disturbance, and symptom severity, with benefits maintained at follow-up, but did not significantly improve pain, physical functioning, or cortisol levels.", "population_specificity": "Female fibromyalgia patients", "effective_dosage": "Not specified", "study_duration": "Post-program and 2-month follow-up (exact intervention duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:32.434440+00:00"}
{"study_id": 85292, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the potential of mindfulness-based treatments as an alternative option for managing depression and anxiety in people with COPD.", "results_summary": "The abstract states that mindfulness-based treatments are an alternative option for managing depression and anxiety in long-term conditions, but their efficacy is unproven in COPD. No specific results on effectiveness are provided.", "population_specificity": "Individuals with chronic obstructive pulmonary disease (COPD) experiencing comorbid symptoms of depression and anxiety.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:34.436944+00:00"}
{"study_id": 85293, "supplement_id": 1338, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers sought to summarize the literature on mindfulness-based interventions and determine their impact on binge eating behavior.", "results_summary": "Most studies showed large-magnitude effects, with meta-analyses supporting large or medium-large effects on binge eating (within-group Hedge's g = -1.12; between-group Hedge's g = -0.70), though statistical heterogeneity was high.", "population_specificity": "Individuals with binge eating behavior.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:34.521484+00:00"}
{"study_id": 75910, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of N-acetylcysteine in preventing contrast-induced acute kidney injury (CI-AKI) in high-risk patients.", "results_summary": "The study found that the evidence supporting N-acetylcysteine for CI-AKI prevention is moderate and remains controversial, with no robust data confirming its effectiveness.", "population_specificity": "Patients with pre-existing chronic kidney disease (CKD) undergoing cardiac procedures involving iodinated contrast media.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:41.641502+00:00"}
{"study_id": 75911, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of N-Acetylcysteine in reducing exacerbations in obstructive lung diseases, particularly COPD.", "results_summary": "The study found strong evidence supporting N-Acetylcysteine's effectiveness in decreasing the risk of COPD exacerbations. It also highlighted its mucolytic properties and broader use outside the United States for obstructive lung diseases.", "population_specificity": "Patients with obstructive lung diseases, especially COPD.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:41.674099+00:00"}
{"study_id": 75908, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the clinical therapeutic uses of N-Acetylcysteine, including its role as a mucolytic agent and in treating disorders linked to glutathione deficiency.", "results_summary": "The study highlights NAC's efficacy as a mucolytic agent and its potential in treating conditions associated with glutathione deficiency, along with its anti-inflammatory properties.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:41.861502+00:00"}
{"study_id": 75906, "supplement_id": 1364, "safety_score": "85", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to systematically review the efficacy of N-acetylcysteine (NAC) in treating obsessive-compulsive disorder (OCD).", "results_summary": "Pooled results showed a mean reduction in Y-BOCS scores after NAC treatment, trending toward favoring NAC over placebo, though statistical significance was borderline. NAC demonstrated an optimal tolerability profile with mostly gastrointestinal adverse events.", "population_specificity": "Patients with obsessive-compulsive disorder (OCD).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:42.045339+00:00"}
{"study_id": 75912, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential beneficial effects of N-Acetylcysteine as an antioxidant in peritoneal dialysis patients experiencing oxidative stress.", "results_summary": "The study suggests that N-Acetylcysteine, along with other antioxidants, may have beneficial effects in reducing oxidative stress in peritoneal dialysis patients, though specific results for N-Acetylcysteine alone are not detailed. However, these findings have not yet led to clinical recommendations.", "population_specificity": "Peritoneal dialysis patients with excessive oxidative stress.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:42.228390+00:00"}
{"study_id": 75907, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine if perioperative N-acetylcysteine, combined with selenium and vitamin C, could reduce the incidence and severity of acute kidney injury after off-pump coronary bypass graft surgery.", "results_summary": "The study found no significant differences in the incidence, severity, or duration of acute kidney injury, nor in secondary outcomes like ICU stay or mortality, between the N-acetylcysteine group and other groups. The intervention was ineffective in preventing acute kidney injury or associated complications.", "population_specificity": "291 patients undergoing elective off-pump coronary bypass graft surgery.", "effective_dosage": "600 mg N-acetylcysteine orally twice daily.", "study_duration": "From the day before surgery to 2 days after surgery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:43.468183+00:00"}
{"study_id": 75913, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the impact of probenecid and N-acetylcysteine combination therapy on glutathione-related pathways and other metabolic networks in children with severe traumatic brain injury.", "results_summary": "The study found that the combination therapy enriched seven glutathione-centered pathways and two networks in cerebrospinal fluid compared to placebo, suggesting therapeutic target engagement. Several additional pathways/networks linked to probenecid-inhibitable transporters were also identified.", "population_specificity": "Children aged 2-18 years with severe traumatic brain injury and five age-matched controls.", "effective_dosage": "Probenecid (25 mg/kg) and N-acetylcysteine (140 mg/kg) administered via naso/orogastric tube.", "study_duration": "Not specified (samples analyzed 24 hours after the first dose).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:43.568887+00:00"}
{"study_id": 75914, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to elucidate the biotransformation pathway of LZDO and the role of N-Acetylcysteine (NAC) as a trapping agent in metabolite formation.", "results_summary": "The study identified 2-NAC-LZDO as a major metabolite in human liver cytosol, with sulfotransferase (SULT) activity, particularly SULT1A1, playing a key role in its formation. NAC was used to trap reactive intermediates, demonstrating its role in the metabolic pathway of LZDO.", "population_specificity": "Liver cytosol from humans, monkeys, dogs, and rats.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:44.158690+00:00"}
{"study_id": 75919, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the role of N-Acetylcysteine in reducing mortality in patients with acetaminophen-induced acute liver failure.", "results_summary": "The study found that N-Acetylcysteine is recommended for all patients with APAP-induced acute liver failure and reduces mortality. Liver transplantation should be considered early for those unlikely to survive based on prognostic criteria.", "population_specificity": "Patients with acetaminophen-induced acute liver failure.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:49.917509+00:00"}
{"study_id": 75918, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to determine whether N-Acetylcysteine could be safely and effectively administered in non-ICU settings for acetaminophen-induced acute liver failure (ALF).", "results_summary": "The study found that N-Acetylcysteine can be administered in non-ICU settings for acetaminophen-induced ALF, minimizing treatment delays without compromising safety or efficacy.", "population_specificity": "Patients with acute liver failure, specifically acetaminophen-induced ALF.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:50.084853+00:00"}
{"study_id": 75917, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the clinical efficacy of N-acetylcysteine (NAC) as an adjunctive treatment for depression and anxiety symptoms and its effects on hs-CRP levels.", "results_summary": "The study found that individuals receiving NAC had a statistically significant reduction in depressive symptoms compared to placebo, as measured by the HDRS17. No significant differences were observed in other measures like anxiety, disability, quality of life, or metabolic parameters.", "population_specificity": "Individuals with depression and anxiety symptoms (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:50.522306+00:00"}
{"study_id": 75921, "supplement_id": 1364, "safety_score": "80", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect sizes of N-Acetylcysteine (NAC) on cardiac hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy (HCM).", "results_summary": "NAC treatment for 12 months showed small effect sizes on indices of cardiac hypertrophy and fibrosis. The study's small sample size limited definitive conclusions about NAC's efficacy in HCM.", "population_specificity": "Patients with HCM and left ventricular wall thickness \u226515 mm.", "effective_dosage": "Titrated up to 2.4 g per day.", "study_duration": "12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:51.256384+00:00"}
{"study_id": 75922, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to assess whether oral N-Acetylcysteine (NAC) as an adjuvant therapy improves clinical outcomes in patients with active Rheumatoid Arthritis (RA).", "results_summary": "The study found no significant differences in disease activity (DAS28) or ESR between NAC and placebo groups, but NAC significantly improved Global Health (GH), pain severity (VAS), and physical performance (HAQ) scores.", "population_specificity": "51 patients with active Rheumatoid Arthritis (RA).", "effective_dosage": "600 mg NAC twice daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:52.080708+00:00"}
{"study_id": 75920, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether N-Acetylcysteine could rapidly increase reduced glutathione (GSH) levels in neonates with hypoxic-ischemic encephalopathy (HIE) during the subacute phase.", "results_summary": "N-Acetylcysteine significantly increased GSH levels from 1.64 \u00b1 0.20 mM to 1.93 \u00b1 0.23 mM within 12-30 minutes post-infusion (p < 0.0001), demonstrating a rapid and measurable effect on oxidative stress in HIE neonates. The study also noted GSH improvement in a perinatal stroke patient.", "population_specificity": "Term neonates with hypoxic-ischemic encephalopathy (HIE) on day of life 5-6, post-therapeutic hypothermia.", "effective_dosage": "Not specified", "study_duration": "Single intravenous infusion, effects measured within 12-30 minutes post-administration.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:53.314926+00:00"}
{"study_id": 75923, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to study NAC's impact on symptoms and neurocognition in early psychosis patients and explore whether glutathione/redox markers could serve as biomarkers for treatment guidance.", "results_summary": "NAC did not improve negative or positive symptoms but showed significant neurocognitive improvements (processing speed) and increased brain and blood glutathione levels. Subgroup analysis suggested a link between redox status changes and positive symptom improvements in patients with high baseline GPx activity.", "population_specificity": "63 early psychosis patients", "effective_dosage": "2700 mg/day", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:57.521481+00:00"}
{"study_id": 75924, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize current treatment options, including the use of nebulized N-acetylcysteine, for managing mucus casts in subglottic inhalation injury.", "results_summary": "The study supports the use of nebulized N-acetylcysteine for treating mucus casts in subglottic inhalation injury, noting its role in multimodal therapy to improve ventilation. However, it highlights the lack of globally accepted standard treatments and the need for more clinical research.", "population_specificity": "Patients with subglottic inhalation injury, particularly burn victims.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:58.223912+00:00"}
{"study_id": 75925, "supplement_id": 1364, "safety_score": "85", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy and safety of adjunctive N-acetylcysteine (NAC) in treating major depressive disorder (MDD), bipolar disorder, and schizophrenia.", "results_summary": "Adjunctive NAC significantly improved total psychopathology in schizophrenia but showed no efficacy for bipolar disorder or MDD. The treatment was found to be safe across the studied conditions.", "population_specificity": "Patients with schizophrenia (n=307), bipolar disorder (n=125), and MDD (n=269).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:48:59.163025+00:00"}
{"study_id": 75926, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study hypothesized that multiday POMx supplementation, potentially combined with a thiol antioxidant like N-Acetylcysteine, would decrease oxygen uptake (VO\u2082) during exercise.", "results_summary": "The abstract does not provide specific results regarding N-Acetylcysteine's effects, only suggesting that its combination with POMx may enhance efficacy compared to POMx alone.", "population_specificity": "Trained athletes and untrained individuals (implied but not specified for N-Acetylcysteine).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:00.096393+00:00"}
{"study_id": 75927, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of N-Acetylcysteine (NAC) on alcohol use among individuals with cannabis use disorder (CUD) enrolled in a cannabis cessation trial.", "results_summary": "NAC was associated with increased odds of alcohol abstinence, fewer drinks per week, and fewer drinking days per week compared to placebo, suggesting a ~30% reduction in alcohol consumption. Changes in cannabis use did not correlate with alcohol use outcomes.", "population_specificity": "Adults aged 18-50 with cannabis use disorder (CUD), not necessarily seeking alcohol cessation.", "effective_dosage": "1200 mg, twice daily", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:00.926395+00:00"}
{"study_id": 75928, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 84, "quality_score": 92, "study_goal": "The researchers aimed to evaluate the relative efficacy of N-Acetylcysteine (NAC) and other pharmacological interventions in preventing contrast-induced nephropathy (CIN) in patients undergoing coronary angiography (CAG).", "results_summary": "NAC plus intravenous saline reduced the incidence of CIN (RR 0.84) and was associated with lower short-term all-cause mortality (RR 0.62) compared to saline alone. However, NAC did not reduce the requirement for dialysis or major adverse cardiac and cerebrovascular events (MACCE).", "population_specificity": "Patients undergoing coronary angiography (CAG).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:01.767864+00:00"}
{"study_id": 75929, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the efficacy of N-Acetylcysteine as a medical therapy for reducing epistaxis severity and frequency in patients with hereditary hemorrhagic telangiectasia (HHT).", "results_summary": "N-Acetylcysteine demonstrated promising efficacy in small trials for managing epistaxis in HHT patients, though the data were heterogeneous and limited by small sample sizes.", "population_specificity": "Patients with hereditary hemorrhagic telangiectasia (HHT) experiencing recurrent epistaxis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:05.824862+00:00"}
{"study_id": 75931, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review pharmacologic treatments for Tourette syndrome, including N-Acetylcysteine, to assess its efficacy and evidence base.", "results_summary": "The abstract states that N-Acetylcysteine has insufficient data for efficacy in treating Tourette syndrome, placing it among agents without sufficient evidence. No specific results on its effects are provided.", "population_specificity": "Individuals with Tourette syndrome (neurodevelopmental disorder characterized by tics).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:06.663527+00:00"}
{"study_id": 75930, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether adding N-Acetylcysteine (NAC) to granulocyte colony-stimulating factor (G-CSF) and standard medical therapy could improve survival and liver function in patients with severe alcoholic hepatitis.", "results_summary": "The study found no evidence of benefit from adding NAC to G-CSF and standard therapy, as the combination group showed no significant improvement in survival or liver function scores compared to G-CSF alone. The G-CSF group outperformed both the combination and standard therapy groups in survival and liver function metrics.", "population_specificity": "Patients with severe alcoholic hepatitis admitted to a Liver Intensive Care unit in India.", "effective_dosage": "Intravenous NAC for 5 days (exact dosage not specified).", "study_duration": "5 days of intervention, with follow-up assessments up to 90 days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:08.255853+00:00"}
{"study_id": 75932, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to explore the potential immunomodulating effects of N-acetylcysteine as an adjunctive therapy for severe influenza.", "results_summary": "The abstract mentions N-acetylcysteine as having supportive preclinical or observational clinical data for immunomodulation in severe influenza, but no specific results or outcomes are detailed. Further investigation via RCTs is recommended.", "population_specificity": "Patients hospitalized with severe influenza (e.g., avian influenza A(H5N1), A(H7N9), and seasonal A(H1N1)pdm09 virus infections.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:09.760879+00:00"}
{"study_id": 75934, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of antioxidant therapy (including N-Acetylcysteine) on oxidative stress biomarkers and clinical outcomes in critically ill polytrauma patients.", "results_summary": "The study found that antioxidant therapy (N-Acetylcysteine combined with Vitamin C) significantly improved multiple biochemical parameters, reduced APACHE II scores, and lowered sepsis incidence and mortality rates compared to the control group.", "population_specificity": "Critically ill polytrauma patients in an intensive care unit.", "effective_dosage": "Not specified (continuous intravenous infusion).", "study_duration": "Daily until discharge or death (exact duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:09.963404+00:00"}
{"study_id": 75933, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the impact of high-dose N-Acetylcysteine (NAC) on ischemia/reperfusion injury in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention (PCI).", "results_summary": "High-dose NAC significantly reduced highly sensitive troponin T (hs-TnT) levels and improved coronary blood flow (TIMI flow grade 3) compared to the control group, though no significant differences were observed in peak CK-MB levels, cTFC, or MBG.", "population_specificity": "100 consecutive patients with ST-elevation myocardial infarction undergoing PCI.", "effective_dosage": "100 mg/kg bolus followed by intracoronary NAC 480 mg during PCI, then intravenous NAC 10 mg/kg for 12 hours.", "study_duration": "12 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:10.146486+00:00"}
{"study_id": 75935, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore the mechanisms of ferroptosis in neurodegenerative and psychiatric disorders and discuss potential therapeutic approaches, including the role of N-Acetylcysteine.", "results_summary": "The abstract discusses ferroptosis as a driver of cell death in neurological diseases and highlights oxidative stress, iron homeostasis, and neuroinflammation as key factors. It mentions negative regulation of ferroptosis by glutathione and related pathways but does not provide specific results on N-Acetylcysteine.", "population_specificity": "Not specified (theoretical focus on neurodegenerative and psychiatric disorders).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:14.101648+00:00"}
{"study_id": 75936, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of N-Acetylcysteine as a novel therapy for smoking cessation, comparing its efficacy and promise against existing treatments.", "results_summary": "The study found that N-Acetylcysteine, among other novel therapies, displayed promising results for smoking cessation, though direct comparisons were challenging due to varied endpoints and outcome measures across trials.", "population_specificity": "Smokers seeking cessation treatment (specific demographics not detailed in the abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:14.402476+00:00"}
{"study_id": 75937, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of N-Acetylcysteine (NAC) and working memory training on reducing cocaine use and craving, as well as improving cognitive inhibition in cocaine-using men.", "results_summary": "NAC reduced cocaine problems and the proportion of cocaine-positive urines but showed no effects on craving. It improved cognitive inhibition in lab tests but had mixed effects on Stroop performance during EMA. No significant effects were found from working memory training.", "population_specificity": "Cocaine-using men (24 out of 38 completed the study).", "effective_dosage": "2400mg/day", "study_duration": "25 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:16.735536+00:00"}
{"study_id": 75939, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 40, "study_goal": "The researchers aimed to explore the potential of N-Acetylcysteine as a neuro- and cardioprotective agent in fetal growth restriction.", "results_summary": "Early research suggests N-Acetylcysteine may have potential benefits, but data from human pregnancies, particularly those with fetal growth restriction, remain very limited.", "population_specificity": "Pregnancies with fetal growth restriction (specific details not provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:16.863453+00:00"}
{"study_id": 75940, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to explore the mechanisms of sulfur mustard-induced lung damage and evaluate the potential of N-Acetylcysteine (NAC) to mitigate these effects.", "results_summary": "The study suggests that NAC may help patients recover from sulfur mustard-induced lung damage by addressing oxidative stress and inflammation, though no definitive treatment outcomes are provided.", "population_specificity": "Individuals exposed to sulfur mustard (military and civilians).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:17.487127+00:00"}
{"study_id": 75938, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy of an MCJ inhibitor against N-Acetylcysteine in treating acetaminophen-induced liver injury.", "results_summary": "The study found that N-Acetylcysteine had no efficacy at the time when the MCJ inhibitor protected the liver from acetaminophen-induced injury. Elevated MCJ levels were also observed in patients with acetaminophen overdose.", "population_specificity": "Patients with acetaminophen-induced liver injury (animal model and human liver samples).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:17.516008+00:00"}
{"study_id": 75915, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 10, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of N-Acetylcysteine as a treatment option for severe alcoholic hepatitis (AH).", "results_summary": "The study found that N-Acetylcysteine, along with other treatments like infliximab and silymarin, is not effective in treating severe AH.", "population_specificity": "Patients with severe alcoholic hepatitis (AH).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:21.451476+00:00"}
{"study_id": 75942, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the antidepressant efficacy of N-acetylcysteine in patients with mood disorders, specifically MDD and BD, as part of immune-based treatment strategies.", "results_summary": "The study found that N-acetylcysteine showed promising results in terms of antidepressant efficacy in patients with MDD and BD, though the results are preliminary and require replication in larger clinical settings.", "population_specificity": "Patients with major depressive disorder (MDD) and bipolar disorder (BD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:22.351638+00:00"}
{"study_id": 75941, "supplement_id": 1364, "safety_score": "75", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential of N-acetylcysteine in promoting cognitive health and alleviating cognitive decline associated with dementia, including its mechanisms of action, effects on aging biology, and safety of long-term use.", "results_summary": "The study found that N-acetylcysteine may increase glutathione levels to counter oxidative stress and improve cognitive function, but evidence for its efficacy alone is less robust. A nutraceutical formulation containing N-acetylcysteine showed some pro-cognitive benefits, though low bioavailability is a limitation.", "population_specificity": "Alzheimer's disease patients and older adults.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:23.443881+00:00"}
{"study_id": 75916, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine if N-Acetylcysteine (NAC) could reduce tubular kidney injury in deceased-donor kidney transplant recipients by measuring urinary neutrophil gelatinase-associated lipocalin (u-NGAL) levels and early graft function.", "results_summary": "NAC significantly reduced u-NGAL levels compared to placebo (p=0.02), indicating reduced tubular injury, but the improvement in early graft function was not statistically significant. The study suggests NAC may have renoprotective effects, though larger trials are needed to confirm its impact on graft function.", "population_specificity": "Deceased-donor kidney transplant recipients (n=70).", "effective_dosage": "600 mg oral NAC twice daily.", "study_duration": "5 days (from day 0 to day 5 post-transplantation).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:24.195081+00:00"}
{"study_id": 75944, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether N-Acetylcysteine (NAC) could reverse the anticancer effects of a combination of epothilone A and metformin by mitigating reactive oxygen species (ROS) generation.", "results_summary": "NAC supplementation partially reversed the anticancer effects of the drug combination, suggesting that ROS generation is required to induce apoptosis in HepG2 and SKOV-3 cancer cells. The study did not assess NAC's standalone efficacy or safety.", "population_specificity": "HepG2 (liver cancer) and SKOV-3 (ovarian cancer) cell lines.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:24.919008+00:00"}
{"study_id": 75943, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether N-acetylcysteine (NAC) could mitigate ITC-induced cell death in Candida albicans by scavenging reactive oxygen species (ROS).", "results_summary": "NAC pretreatment recovered ITC-induced cell death, indicating that ROS plays a key role in ITC's antifungal activity. NAC also attenuated mitochondrial dysfunction and apoptotic features caused by ITC.", "population_specificity": "Candida albicans (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:25.405978+00:00"}
{"study_id": 75945, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the efficacy of adjunctive N-Acetylcysteine (NAC) in periodontal treatment compared to surgery alone.", "results_summary": "NAC adjunctive therapy showed a significant reduction in probing depth at 3 months compared to surgery alone, but no significant differences in other clinical parameters or sRANKL levels were observed by 7 months.", "population_specificity": "Thirty subjects with moderate-to-severe chronic periodontitis.", "effective_dosage": "600 mg NAC.", "study_duration": "7 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:25.448674+00:00"}
{"study_id": 75946, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether intravenous N-acetylcysteine and ascorbic acid could reduce the incidence of contrast-induced nephropathy in critically ill patients undergoing contrast-enhanced computed tomography.", "results_summary": "The study found no significant reduction in contrast-induced nephropathy incidence with N-acetylcysteine and ascorbic acid compared to the control group (18.33% vs. 15.6%, p=0.81). However, treated patients showed significantly lower 8-isoprostane levels and a smaller increase in serum cystatin-C compared to controls.", "population_specificity": "Critically ill patients with stable renal function undergoing non-urgent contrast-enhanced computed tomography.", "effective_dosage": "1200 mg N-acetylcysteine and 2 g ascorbic acid, administered intravenously 2 hours before, and at 10 and 18 hours after contrast infusion.", "study_duration": "Approximately 24 hours (from pre-contrast administration to final measurement).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:28.195789+00:00"}
{"study_id": 75947, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the in vivo and in vitro performance of two N-Acetylcysteine formulations (granules vs. tablet) and assess the impact of dosage form and water coadministration on drug release.", "results_summary": "The study found that drug plasma concentrations were similar for tablets with water and granules with or without water. Dissolution was slow (around 30% until gastric emptying) and unaffected by water coadministration or formulation, suggesting gastric emptying kinetics primarily controlled absorption.", "population_specificity": "11 healthy volunteers", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:29.657549+00:00"}
{"study_id": 75948, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to understand the mechanisms of APAP-induced liver injury and the role of N-Acetylcysteine as an antidote, focusing on mitochondrial dysfunction and cell death pathways.", "results_summary": "The study confirmed N-Acetylcysteine's effectiveness in scavenging reactive metabolites from APAP overdose, highlighting its role as the only clinically used treatment. It also identified mitochondrial dysfunction and oxidative stress as key factors in APAP-induced liver injury.", "population_specificity": "Patients with APAP-induced acute liver failure (general context, not a specific study population).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:30.604327+00:00"}
{"study_id": 75952, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not mention N-Acetylcysteine or its study.", "results_summary": "The abstract does not discuss N-Acetylcysteine or its effects.", "population_specificity": "Not specified (abstract focuses on acute liver failure generally).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:31.774894+00:00"}
{"study_id": 75950, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the therapeutic potential of N-Acetylcysteine, in combination with minocycline, for targeting inflammatory and oxidative stress pathways in neuropsychiatric disorders.", "results_summary": "The study suggests that N-Acetylcysteine, alongside minocycline, may effectively target pathways like TNF-\u03b1, PARP-1, and NLRP3 inflammasome to mitigate neuroinflammation and oxidative stress in neuropsychiatric disorders.", "population_specificity": "Patients with neurodegenerative and neuroprogressive disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:32.415349+00:00"}
{"study_id": 75949, "supplement_id": 1364, "safety_score": "80", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to determine if N-Acetylcysteine (NAC) could reduce nonsuicidal self-injury (NSSI) frequency and improve related psychiatric symptoms in adolescents and young adults.", "results_summary": "NAC treatment significantly reduced NSSI frequency and improved depression and global psychopathology scores, though impulsivity scores remained unchanged. The reduction in NSSI was independent of improvements in depression or psychopathology.", "population_specificity": "Female adolescents and young adults aged 13-21 with NSSI.", "effective_dosage": "600 mg twice daily (weeks 1-2), 1200 mg twice daily (weeks 3-4), 1800 mg twice daily (weeks 5-8).", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:32.686085+00:00"}
{"study_id": 75953, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate whether intravenous N-acetylcysteine (NAC) could prevent postoperative atrial fibrillation (AF) after coronary artery bypass graft (CABG) surgery.", "results_summary": "NAC significantly reduced the incidence of postoperative AF (5.6% vs. 18.8% in the placebo group) and showed a different hsCRP level trend, indicating reduced inflammation. The use of NAC was the only predictor of reduced AF in multivariable analysis.", "population_specificity": "150 patients scheduled for on-pump CABG surgery.", "effective_dosage": "50 mg/kg intravenous NAC infusion after anesthesia induction, plus two additional doses on postoperative days 1 and 2.", "study_duration": "3 days (perioperative and postoperative days 1-2).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:34.518602+00:00"}
{"study_id": 75951, "supplement_id": 1364, "safety_score": "100", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether premedication with simethicone plus N-acetylcysteine (NAC) improves mucosal visibility during upper GI endoscopy compared to simethicone alone or no intervention.", "results_summary": "Premedication with S+NAC500 and S+NAC1000 significantly improved gastric visibility compared to no intervention or water alone, with no adverse reactions reported. Simethicone alone did not show improvements in visibility.", "population_specificity": "230 patients (68% female, mean age 49 years) undergoing upper GI endoscopy, primarily for epigastric pain/dyspepsia.", "effective_dosage": "500 mg or 1000 mg NAC combined with 200 mg simethicone, ingested once 20 minutes before the procedure.", "study_duration": "Single administration 20 minutes before the procedure.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:34.755745+00:00"}
{"study_id": 75954, "supplement_id": 1364, "safety_score": "80", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to establish the maximum tolerated dose (MTD) and pharmacokinetics of intravenous (IV) and intra-arterial (IA) N-Acetylcysteine (NAC) in adults with chronic kidney disease for potential oto- and nephroprotection in pediatric patients receiving platinum therapy.", "results_summary": "The study found that 450 mg/kg NAC was the MTD for both IV and IA administration, with no severe toxicity observed at this dose. Serum NAC levels reached 2-3 mM, a concentration previously associated with nephroprotection in preclinical studies.", "population_specificity": "Adults with stage three or worse renal failure undergoing endovascular procedures.", "effective_dosage": "150, 300, 450, 600, 900, and 1200 mg/kg NAC (IV or IA).", "study_duration": "Single-dose administration.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:38.371542+00:00"}
{"study_id": 75957, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 60, "study_goal": "The researchers aimed to characterize the pharmacokinetics of repeated high oral doses of NAC and their effect on brain and blood oxidative stress measures in individuals with Parkinson's disease and healthy controls.", "results_summary": "The study found that intravenous administration of high-dose NAC increased blood and brain glutathione (GSH) levels in individuals with Parkinson's disease, Gaucher disease, and healthy controls, suggesting potential antioxidant benefits. However, the abstract does not provide detailed efficacy outcomes for oral NAC.", "population_specificity": "Individuals with Parkinson's disease (n=5) and healthy controls (n=3).", "effective_dosage": "High oral doses (specific amount not stated).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:39.367084+00:00"}
{"study_id": 75958, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether N-acetylcysteine (2400 mg) affects glutamate and gamma-aminobutyric acid concentrations in the dorsal anterior cingulate cortex and influences smoking cessation.", "results_summary": "The study found no significant effects of N-acetylcysteine on neurotransmitter concentrations, smoking cessation, craving, or withdrawal symptoms, despite confirming baseline glutamate imbalance in smokers.", "population_specificity": "48 smokers (compared to 47 non-smoking males as baseline controls).", "effective_dosage": "2400 mg (daily, assumed).", "study_duration": "14 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:39.673382+00:00"}
{"study_id": 75959, "supplement_id": 1364, "safety_score": "75", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential effectiveness and safety of glutamatergic agents, including N-Acetylcysteine, in treating compulsivity/impulsivity in pediatric psychiatric disorders.", "results_summary": "The study found that N-Acetylcysteine showed a favorable risk-benefit profile among glutamatergic agents, suggesting potential value for treating compulsivity/impulsivity in children and adolescents, though trial designs and results were heterogeneous.", "population_specificity": "Pediatric patients with obsessive-compulsive disorder, autism spectrum disorders, and attention deficit/hyperactivity disorder.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:41.068270+00:00"}
{"study_id": 75960, "supplement_id": 1364, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to assess the efficacy of N-Acetylcysteine (NAC) for reducing craving symptoms in substance use disorders (SUDs) through a systematic review of randomized clinical trials (RCTs).", "results_summary": "NAC was significantly superior to placebo for craving reduction in SUDs (Hedges' g = 0.94; 95%CI 0.55-1.33). The study noted low publication bias and non-significant heterogeneity, though limitations included a small number of trials and methodological variability.", "population_specificity": "Individuals with substance use disorders (n = 245 across seven RCTs).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:41.997260+00:00"}
{"study_id": 75956, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to determine whether calcium supplementation combined with N-Acetylcysteine and other antioxidants/supplements could reduce pre-eclampsia and adverse pregnancy outcomes.", "results_summary": "The study found that calcium plus N-Acetylcysteine and other supplements may slightly reduce pre-eclampsia and early pregnancy loss, but results were uncertain due to wide confidence intervals and small sample size. A reduction in composite outcomes (pre-eclampsia and/or pregnancy loss) was observed, but the effects could not be attributed solely to N-Acetylcysteine.", "population_specificity": "60 pregnant women with low antioxidant status in early pregnancy (8-12 weeks gestation) at an academic hospital in Indonesia.", "effective_dosage": "200 mg N-Acetylcysteine (alongside 800 mg calcium and other supplements), taken twice daily.", "study_duration": "From 8-12 weeks of gestation until delivery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:42.011919+00:00"}
{"study_id": 75961, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to determine whether resveratrol supplementation could reduce sleep disorders in patients with chronic hepatitis C treated with Peg-IFN-\u03b1 and RBV.", "results_summary": "The study found that resveratrol supplementation decreased General Health Questionnaire scores and reduced sleep disorders in the treated group compared to the placebo group after six months.", "population_specificity": "Patients with chronic hepatitis C treated with Peg-IFN-\u03b1 and RBV.", "effective_dosage": "Not specified for N-Acetylcysteine.", "study_duration": "Six months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:42.235302+00:00"}
{"study_id": 75962, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of N-Acetylcysteine in preventing acute kidney injury (AKI) after cardiac surgery compared to other pharmacologic strategies.", "results_summary": "The study found that N-Acetylcysteine had an odds ratio (OR) of 0.85 (95% CI 0.64-1.14) for preventing AKI, indicating a modest but non-significant reduction in risk compared to placebo. It ranked lower in efficacy compared to other interventions like natriuretic peptide and fenoldopam.", "population_specificity": "Adult patients undergoing cardiac surgery, particularly those at high risk of AKI.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:43.772060+00:00"}
{"study_id": 75963, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to assess the role of N-Acetylcysteine (NAC) in the treatment of acute liver failure (ALF), particularly in cases of idiosyncratic drug-induced liver injury (iDILI).", "results_summary": "The study suggests NAC may be considered as part of the treatment for ALF caused by iDILI, alongside withdrawal of the offending agent and intensive care. However, the abstract does not provide specific efficacy data or outcomes related to NAC.", "population_specificity": "Patients with acute liver failure, particularly those with idiosyncratic drug-induced liver injury.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:47.088640+00:00"}
{"study_id": 75965, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the effectiveness of N-Acetylcysteine as a potential treatment for toxic epidermal necrolysis (TEN) among other interventions.", "results_summary": "The abstract mentions N-Acetylcysteine as one of the treatments trialed for TEN, but no specific efficacy data or comparative results are provided. It states that no gold standard treatment has been established, implying mixed or inconclusive outcomes for N-Acetylcysteine.", "population_specificity": "Patients with toxic epidermal necrolysis (TEN).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:48.332747+00:00"}
{"study_id": 75964, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy of N-Acetylcysteine, among other mucolytics, in reducing COPD exacerbations through meta-analyses of randomized clinical trials.", "results_summary": "N-Acetylcysteine at 1,200 mg/day significantly reduced the odds of COPD exacerbations compared to placebo (OR 0.56, 95% CI 0.35-0.92; p < 0.05), with high-quality evidence. However, N-Acetylcysteine at 600 mg/day showed no significant effect.", "population_specificity": "Patients with chronic obstructive pulmonary disease (COPD), particularly those with frequent exacerbations.", "effective_dosage": "1,200 mg/day and 600 mg/day", "study_duration": "At least 3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:48.898227+00:00"}
{"study_id": 75966, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential synergy of N-Acetylcysteine with antimicrobial agents to enhance their efficacy and reduce antimicrobial resistance.", "results_summary": "The review identified N-Acetylcysteine as one of the antioxidants that can act synergistically with antimicrobial drugs, potentially enhancing their effectiveness and mitigating resistance. However, specific mechanistic details or clinical outcomes for N-Acetylcysteine were not highlighted.", "population_specificity": "Not specified (broad focus on antimicrobial resistance modulation).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:49.430707+00:00"}
{"study_id": 75969, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of oxidative stress-responsive miR-92a in chronic kidney disease (CKD) and its potential link to endothelial dysfunction.", "results_summary": "The study found that serum miR-92a levels increased with decreased kidney function in CKD patients, and uremic toxins like indoxyl sulfate induced miR-92a levels in endothelial cells, suppressing protective molecules. The abstract mentions the antioxidant N-Acetylcysteine but does not detail its effects.", "population_specificity": "Patients with chronic kidney disease (CKD) from three clinical sites.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:50.482484+00:00"}
{"study_id": 75967, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to determine whether N-Acetylcysteine (NAC), alone or in combination with acetazolamide (ACZ), could reduce hematocrit levels and improve oxygenation in patients with chronic mountain sickness (CMS).", "results_summary": "The study evaluated NAC's effects on hematocrit and PaO\u2082 levels in CMS patients, but the abstract does not specify the magnitude or statistical significance of NAC's impact compared to placebo or other treatments.", "population_specificity": "Patients with chronic mountain sickness (CMS) in Cerro de Pasco, Peru (4380m), with hematocrit \u226565% and CMS score >6.", "effective_dosage": "Not specified", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:52.169136+00:00"}
{"study_id": 75971, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore the potential of N-Acetylcysteine as a promising agent in the therapeutic landscape of thrombotic thrombocytopenic purpura (TTP).", "results_summary": "The abstract mentions N-Acetylcysteine as a promising agent under evaluation but does not provide specific results regarding its effects.", "population_specificity": "Patients with thrombotic thrombocytopenic purpura (TTP).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:54.850224+00:00"}
{"study_id": 75973, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate N-acetylcysteine as a potential radiation countermeasure for astronauts, examining its preclinical and clinical evidence.", "results_summary": "The abstract suggests N-acetylcysteine is among the FDA-approved agents warranting further investigation for radiation protection in astronauts, but specific results on its efficacy are not detailed.", "population_specificity": "Astronauts (potential application)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:55.527272+00:00"}
{"study_id": 75970, "supplement_id": 1364, "safety_score": "90", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to verify brain exposure of N-Acetylcysteine (NAC) and probenecid and identify adverse effects of this combination after severe traumatic brain injury (TBI) in children.", "results_summary": "The study found detectable concentrations of NAC and probenecid in CSF with no adverse events attributable to treatment. However, there were no significant differences in clinical outcomes (e.g., Glasgow Outcome Scale, ICP, biomarkers) between the treatment and placebo groups.", "population_specificity": "Children aged 2-18 years with severe TBI (GCS \u22648) requiring an externalized ventricular drain.", "effective_dosage": "NAC (140 mg/kg load, then 70 mg/kg/dose q4h\u00d717 doses); probenecid (25 mg/kg load, then 10 mg/kg/dose q6h\u00d711 doses).", "study_duration": "Intervention lasted for approximately 72 hours (17 doses of NAC and 11 doses of probenecid).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:58.070831+00:00"}
{"study_id": 75976, "supplement_id": 1364, "safety_score": "70", "efficacy_score": 45, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of N-acetylcysteine (NAC) as an augmentation therapy for treatment-resistant obsessive-compulsive disorder (OCD) in adults.", "results_summary": "The study found no significant difference between NAC and placebo in reducing OCD severity, though NAC showed a modest benefit in reducing anxiety symptoms. NAC was generally well tolerated, but abdominal pain was more frequent in the NAC group.", "population_specificity": "Adults aged 18-65 with treatment-resistant OCD, diagnosed per DSM-IV criteria.", "effective_dosage": "3,000 mg daily", "study_duration": "16 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:58.628203+00:00"}
{"study_id": 75974, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether high-dose intravenous N-acetylcysteine (NAC) combined with low-dose nitroglycerin reduces infarct size in ST-segment-elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention.", "results_summary": "The study found that high-dose intravenous NAC with low-dose nitroglycerin was associated with a 5.5% absolute reduction in infarct size compared to placebo. Secondary outcomes included improvements in myocardial salvage and creatine kinase kinetics.", "population_specificity": "Patients with ST-segment-elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention.", "effective_dosage": "29 g of NAC over 2 days (intravenous) with 7.2 mg of nitroglycerin over 2 days (intravenous).", "study_duration": "2 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:49:58.775752+00:00"}
{"study_id": 75977, "supplement_id": 1364, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of N-Acetylcysteine (NAC) on mortality in patients with non-acetaminophen-induced acute liver failure (NAI-ALF) and evaluate its safety and efficacy.", "results_summary": "NAC reduced mortality from 53% to 28%, improved survival, and shortened hospital stays in survived patients. The study concluded NAC is safe and effective for NAI-ALF patients in non-transplant centers.", "population_specificity": "80 patients diagnosed with non-acetaminophen-induced acute liver failure (NAI-ALF).", "effective_dosage": "NAC infusion for 72 hours (specific dosage not mentioned).", "study_duration": "72 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:01.476737+00:00"}
{"study_id": 75975, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of N-Acetylcysteine (NAC) for treating cannabis use disorder (CUD) in adults, comparing it to placebo alongside contingency management.", "results_summary": "The study found no statistically significant difference in cannabis abstinence between the NAC and placebo groups, with similar rates of negative urine tests (22.3% vs. 22.4%). Exploratory analyses in medication-adherent subgroups also showed no significant treatment effects.", "population_specificity": "Treatment-seeking adults aged 18-50 with cannabis use disorder (N=302).", "effective_dosage": "1200mg twice daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:01.859247+00:00"}
{"study_id": 75978, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the role of glutamate transporters in drug addiction and assess whether targeting them, particularly with N-Acetylcysteine, could be an effective treatment strategy.", "results_summary": "The study summarizes preclinical and clinical evidence suggesting that glutamate transporters, including those modulated by N-Acetylcysteine, play a key role in addiction-related behaviors and may offer a viable treatment target for reducing maladaptive drug-seeking behaviors.", "population_specificity": "Preclinical models and clinical studies related to drug addiction (specific population not detailed in abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:03.211535+00:00"}
{"study_id": 75979, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of combining N-Acetylcysteine with corticosteroids on reducing hepatorenal syndrome, infections, and short-term mortality in patients with alcoholic hepatitis.", "results_summary": "The study found that combining N-Acetylcysteine with corticosteroids decreased the development of hepatorenal syndrome, infections, and short-term mortality in patients with severe alcoholic hepatitis. However, the abstract does not provide detailed statistical outcomes or comparative efficacy data for N-Acetylcysteine alone.", "population_specificity": "Patients with severe alcoholic hepatitis (MDF >32, Lille's Score >0.45, or GAHS >9).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:04.589081+00:00"}
{"study_id": 75980, "supplement_id": 1364, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to review the antioxidant and detoxifying effects of sulphur-containing amino acids, including N-Acetylcysteine, against free radicals and toxic metal ions.", "results_summary": "The study found that N-Acetylcysteine, as a derivative of cysteine, contributes to intracellular antioxidant synthesis and offers protective effects against heavy metal toxicity by acting as a chelating agent. It also plays a role in reactivating enzyme inhibition caused by toxic metals.", "population_specificity": "Not specified (literature review).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:06.066517+00:00"}
{"study_id": 75981, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine whether N-Acetylcysteine (NAC) could protect the heart from ischemia-reperfusion (I/R) injury by enhancing antioxidant capacity.", "results_summary": "Pretreatment with NAC attenuated I/R-induced damage to cardiac structures (sarcolemma, sarcoplasmic reticulum, mitochondria, and myofibrils) and improved cardiac function in experimental studies, though clinical trial results were inconclusive, showing both positive and no effects.", "population_specificity": "Hearts exposed to I/R injury (experimental studies) and patients post-cardiac surgery or myocardial infarction (clinical trials).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:07.463156+00:00"}
{"study_id": 75982, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the potential of N-acetylcysteine as a redox modulator in mitigating oxidative stress-linked pathologic fibrosis, particularly in the heart and kidney.", "results_summary": "The study highlights N-acetylcysteine as a promising redox modulator for targeting pathologic fibrosis, with potential benefits in disrupting TGF-\u03b21-mediated profibrotic signals and oxidative stress pathways. However, specific efficacy data or clinical outcomes for N-acetylcysteine were not detailed in the abstract.", "population_specificity": "The study focuses on oxidative stress-linked pathologic fibrosis, particularly in the heart and kidney, using ionizing radiation as a stimulus.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:08.100605+00:00"}
{"study_id": 75983, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to compare the effectiveness of N-Acetylcysteine (NAC) and other strategies in preventing contrast-induced acute kidney injury (CIAKI) in patients undergoing percutaneous coronary procedures.", "results_summary": "The study found that NAC was one of several strategies evaluated, but statin administration showed a more marked and consistent reduction in CIAKI risk compared to saline. The abstract does not provide detailed efficacy results for NAC alone.", "population_specificity": "Patients undergoing percutaneous coronary procedures.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:09.703683+00:00"}
{"study_id": 75984, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether N-Acetylcysteine (NAC) could inhibit ROS generation and improve cell survival in nsPEF-treated cancer cells exposed to low temperatures.", "results_summary": "NAC pre-incubation reduced ROS levels and increased cell survival in nsPEF-treated cells, protecting them from low temperature-induced cell death. The study suggests NAC may mitigate oxidative stress-related damage in this context.", "population_specificity": "Cancer cells treated with nsPEF under varying environmental temperatures (0, 4, 25, and 37\u00b0C).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:10.384070+00:00"}
{"study_id": 75986, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not mention N-Acetylcysteine or its study goals.", "results_summary": "The abstract does not discuss N-Acetylcysteine or its effects.", "population_specificity": "Patients with thrombotic thrombocytopenic purpura (TTP).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:10.997627+00:00"}
{"study_id": 75985, "supplement_id": 1364, "safety_score": "85", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the cognitive effects of N-Acetylcysteine (NAC) across various disorders by reviewing existing literature.", "results_summary": "The review suggested statistically significant cognitive improvements following NAC treatment, but methodological heterogeneity and insufficiently powered studies made it difficult to determine clinical meaningfulness. Larger, targeted studies are needed to confirm these findings.", "population_specificity": "Alzheimer's disease patients, healthy participants, physical trauma patients, bipolar disorder patients, schizophrenia patients, and ketamine-induced psychosis patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:11.645797+00:00"}
{"study_id": 75987, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The study aimed to assess vascular function during acute hyperglycemia induced by sugar-sweetened beverage consumption and its effect on the nitric oxide pathway.", "results_summary": "The study found that sugar-sweetened beverage consumption impaired microvascular and macrovascular endothelial function, likely due to increased oxidative stress reducing nitric oxide bioavailability.", "population_specificity": "12 healthy male participants", "effective_dosage": "Not mentioned", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:13.235530+00:00"}
{"study_id": 75988, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to compare the efficacy of an association of D-mannose, N-acetylcysteine (NAC), and Morinda citrifolia extract versus antibiotic therapy in preventing UTIs following urodynamic examination.", "results_summary": "The study found that the combination of mannose and NAC therapy was similarly effective to antibiotic therapy in preventing UTIs after urodynamic procedures, with no statistically significant difference in UTI incidence between the two groups.", "population_specificity": "80 patients (42 men and 38 women) eligible for urodynamic examination.", "effective_dosage": "Two vials/day of the mannose and NAC combination for 7 days.", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:16.627871+00:00"}
{"study_id": 75989, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to review preliminary data on the safety and efficacy of N-Acetylcysteine, among other agents, for treating OCD, either as monotherapy or in combination with selective serotonin reuptake inhibitors.", "results_summary": "Preliminary data suggest N-Acetylcysteine is safe for use in OCD treatment, but its efficacy has not yet been established. The study did not provide specific outcomes or statistical significance for N-Acetylcysteine.", "population_specificity": "Adults (\u226518 years) with OCD.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:16.783385+00:00"}
{"study_id": 75990, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were evaluating N-Acetylcysteine as a potential alternative biological therapy for youth with mental health problems, focusing on its risk-benefit balance.", "results_summary": "The abstract mentions that N-Acetylcysteine is currently being evaluated, but no specific findings or results are provided regarding its effects.", "population_specificity": "Youth with mental health problems (no specific age range or condition detailed).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:17.265828+00:00"}
{"study_id": 75991, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to explore the effects of adjunctive N-acetylcysteine (NAC) on inflammatory and neurogenesis markers in unipolar depression.", "results_summary": "NAC significantly improved depressive symptoms but did not significantly alter IL6, CRP, or BDNF levels. IL6 was associated with symptom reduction independent of treatment response.", "population_specificity": "Patients with unipolar depression", "effective_dosage": "2000 mg/day", "study_duration": "12 weeks (with a 4-week follow-up)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:18.127498+00:00"}
{"study_id": 75993, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to review the utility of N-acetylcysteine (NAC) in sepsis, focusing on its anti-inflammatory, antioxidative, and vasodilatory properties, and identify areas needing further research.", "results_summary": "The study found mixed results for NAC in sepsis, with some evidence of microcirculatory vasodilation, improved regional blood flow, reduced lactic acidosis, and lower mortality, but overall outcomes were inconsistent.", "population_specificity": "Patients with sepsis or septic shock.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:20.050355+00:00"}
{"study_id": 75992, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of Zn and hypoxia on MTT expression in vitro and in vivo, as part of a sub-study on the prevention of contrast-media-induced nephropathy using N-Acetylcysteine, Zn, or placebo.", "results_summary": "The study found that Zn induced MTT expression in vitro but not in vivo, with no significant impact from hypoxia. A negative correlation between MTT and eGFR in vivo suggested a potential protective role of MTT in reduced kidney function, possibly influenced by Zn.", "population_specificity": "54 patients in a prospective, randomized, double-blind trial.", "effective_dosage": "Not specified for N-Acetylcysteine.", "study_duration": "2 days of Zn administration.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:21.921204+00:00"}
{"study_id": 75994, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy of N-Acetylcysteine with pirfenidone and nintedanib in treating idiopathic pulmonary fibrosis (IPF), focusing on forced vital capacity (FVC) and mortality outcomes.", "results_summary": "The study found no evidence that N-Acetylcysteine had an effect on FVC compared to placebo (difference = 0.01 L, 95% CrI = -0.15-0.17 L) and no difference in all-cause mortality (HR: 2.00, 95% CrI = 0.46-8.62).", "population_specificity": "Adults with idiopathic pulmonary fibrosis (IPF).", "effective_dosage": "Not specified", "study_duration": "1 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:22.356970+00:00"}
{"study_id": 75995, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to determine the effects of oral antioxidant treatment with N-Acetylcysteine on exercise intolerance in early-stage COPD.", "results_summary": "The abstract does not provide results regarding N-Acetylcysteine's effects.", "population_specificity": "Patients with early-stage chronic obstructive pulmonary disease (COPD).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:23.896680+00:00"}
{"study_id": 75997, "supplement_id": 1364, "safety_score": "80", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of N-acetylcysteine as an adjunctive or alternative therapy for bronchiolitis in infants.", "results_summary": "One study (n = 100) showed some benefits of N-acetylcysteine in improving clinical severity scores and symptoms of bronchiolitis, though data were sparse. No serious adverse events were reported.", "population_specificity": "Infants aged 1 month to 2 years with bronchiolitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:25.106673+00:00"}
{"study_id": 75996, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to review the literature on N-Acetylcysteine (NAC) as a pharmacological intervention for cocaine dependence, assessing its potential to reduce craving and relapse.", "results_summary": "NAC showed promise in reducing craving, desire to use cocaine, and cocaine-related behaviors in four clinical studies, with animal studies supporting its role in preventing relapse by restoring glutamate homeostasis. However, a double-blind placebo trial was mainly negative except in already abstinent patients.", "population_specificity": "Individuals with cocaine dependence (clinical and animal studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:25.599171+00:00"}
{"study_id": 75999, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the potential role of N-Acetylcysteine in antagonizing the von Willebrand Factor (VWF) pathway as part of antithrombotic therapy.", "results_summary": "The abstract suggests that N-Acetylcysteine, among other drugs, may have unselective antagonism on the VWF pathway, but specific efficacy data or outcomes for N-Acetylcysteine are not detailed.", "population_specificity": "High-risk cardiovascular populations and patients with valvular heart disease (implied, not explicitly stated).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:28.794042+00:00"}
{"study_id": 76000, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to compare baseline demographic, cannabis use, and psychiatric factors between women and men entering a trial evaluating N-Acetylcysteine for cannabis cessation.", "results_summary": "The study found that cannabis-dependent women reported more severe withdrawal symptoms, psychiatric conditions, and physical health issues compared to men, but no differences in baseline cannabis use were observed. The findings suggest women may require gender-specific treatment approaches.", "population_specificity": "Treatment-seeking cannabis-dependent adults (86 women, 216 men).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:30.610984+00:00"}
{"study_id": 75998, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to determine whether intravenous N-Acetylcysteine (NAC) reduces mortality and the need for liver transplantation in patients with non-acetaminophen-induced acute liver failure (NAI-ALF).", "results_summary": "NAC significantly improved transplant-free survival (96.4% vs. 23.3% in controls), reduced hospital stays, encephalopathy, bleeding, ICU admissions, and organ failure. Liver function markers (bilirubin, AST, INR) also improved in the NAC group.", "population_specificity": "Adults with non-acetaminophen-induced acute liver failure.", "effective_dosage": "Initial dose of 150 mg/kg over 30 min, followed by 70 mg/kg over 4 h, then 70 mg/kg over 16 h, then continuous infusion of 150 mg/kg over 24 h until two consecutive normal INRs were achieved.", "study_duration": "Variable, based on INR normalization.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:30.734418+00:00"}
{"study_id": 76001, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the efficacy of N-Acetylcysteine, among other treatments, in preventing contrast-induced acute kidney injury (CIAKI) in patients undergoing cardiovascular invasive procedures with iodinated contrast.", "results_summary": "The study found that saline plus N-Acetylcysteine significantly reduced the odds of CIAKI (OR 0.72, 95%CrI 0.57-0.88) compared to saline alone, demonstrating its efficacy in prevention. Sodium bicarbonate plus N-Acetylcysteine also showed a strong effect (OR 0.59, 95%CrI 0.36-0.89).", "population_specificity": "Patients undergoing cardiovascular invasive procedures with administration of iodinated contrast.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:32.432864+00:00"}
{"study_id": 76002, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore the potential of N-Acetylcysteine as a promising agent in the therapeutic landscape of thrombotic thrombocytopenic purpura (TTP).", "results_summary": "The abstract mentions N-Acetylcysteine as a promising agent under evaluation for TTP, but no specific results regarding its effects are provided.", "population_specificity": "Patients with thrombotic thrombocytopenic purpura (TTP).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:33.039130+00:00"}
{"study_id": 76004, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effectiveness of N-Acetylcysteine in managing ocular injuries caused by sulfur mustard poisoning.", "results_summary": "N-Acetylcysteine was listed among various treatments for sulfur mustard-induced ocular injuries, suggesting potential benefits, but no specific efficacy data or comparative results were provided.", "population_specificity": "Victims of sulfur mustard poisoning with ocular injuries.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:33.717745+00:00"}
{"study_id": 76003, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of N-Acetylcysteine (NAC) on COPD exacerbation prevalence and changes in lung function parameters in patients with COPD.", "results_summary": "High-dose and low-dose NAC reduced COPD exacerbation prevalence, with long-term (\u22656 months) use showing significant effects. NAC did not affect exacerbation rate or forced expiratory volume in 1 second (FEV1).", "population_specificity": "Patients with chronic obstructive pulmonary disease (COPD) (2,691 participants across 12 trials).", "effective_dosage": "High-dose and low-dose (specific amounts not detailed in abstract).", "study_duration": "Long-term (\u22656 months) and short-term (duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:34.619847+00:00"}
{"study_id": 76007, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were attempting to determine the role of reactive species and free radicals in sepsis pathogenesis and potential implications for N-Acetylcysteine.", "results_summary": "The abstract does not provide specific findings regarding N-Acetylcysteine's effects.", "population_specificity": "Critically ill patients with sepsis.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:37.334031+00:00"}
{"study_id": 76005, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to compare the cost-effectiveness and efficacy of N-Acetylcysteine against nintedanib, pirfenidone, and best supportive care for treating idiopathic pulmonary fibrosis (IPF).", "results_summary": "N-Acetylcysteine showed modest effectiveness similar to best supportive care but with a worse survival profile. It was less effective than nintedanib and pirfenidone in reducing acute exacerbations and lung function decline.", "population_specificity": "Adults with idiopathic pulmonary fibrosis (IPF).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:38.165139+00:00"}
{"study_id": 76006, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether oral antioxidant treatment, including N-Acetylcysteine, could reduce x-ray-induced DNA damage in patients undergoing radiologic procedures.", "results_summary": "The study found that the antioxidant group, which included N-Acetylcysteine, showed significantly fewer gamma-H2AX foci/cell after radiation exposure compared to the control group, indicating reduced DNA damage. No significant difference was observed in the antioxidant group before and after exposure, suggesting a protective effect.", "population_specificity": "Patients undergoing clinically indicated technetium-99m methylene diphosphonate scans.", "effective_dosage": "1.2 g N-Acetylcysteine (part of a combined antioxidant regimen).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:41.328239+00:00"}
{"study_id": 76009, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of N-Acetylcysteine and other antioxidants in preventing or treating noise-induced hearing loss (NIHL) based on molecular studies and animal models.", "results_summary": "The abstract indicates that compounds like N-Acetylcysteine, emerging from molecular studies, are being tested in field trials with encouraging results, though no clinically approved intervention exists yet. Future work needs stricter criteria for noise exposure and outcome parameters to maximize protective therapies.", "population_specificity": "Humans and animal models affected by noise-induced hearing loss (industrial, military, and recreational noise exposure).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:41.667252+00:00"}
{"study_id": 76008, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the role of N-Acetylcysteine in treating drug-induced liver injury (DILI), particularly in early stages, and its impact on transplant-free survival.", "results_summary": "The study found that N-Acetylcysteine provides some benefit in the early stages of DILI, particularly in cases with elevated transaminases or jaundice, but transplant-free survival remains poor in idiosyncratic DILI.", "population_specificity": "Patients with drug-induced liver injury (DILI), particularly those with hepatocellular injury and elevated transaminases.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:41.805252+00:00"}
{"study_id": 76011, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine the cognitive effects of adjunctive N-Acetylcysteine (NAC) treatment in participants with psychosis, focusing on attention, working memory, and executive function.", "results_summary": "Participants treated with NAC showed significantly higher working memory performance at 24 weeks compared to placebo, suggesting potential cognitive benefits in psychosis. However, the study notes these findings are preliminary and require replication.", "population_specificity": "58 participants with psychosis (schizophrenia and bipolar disorder) who completed neuropsychological assessments.", "effective_dosage": "2 g/day", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:43.658880+00:00"}
{"study_id": 76012, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to explore the role of mTORC1 activation in SLE and the potential of N-acetylcysteine, rapamycin, and rapalogs as therapeutic alternatives to current treatments with severe side effects.", "results_summary": "The abstract suggests that targeting mTORC1 over-activation with N-acetylcysteine may offer a therapeutic opportunity for SLE, potentially replacing current therapies like prednisone or cyclophosphamide, but does not provide specific efficacy data for N-acetylcysteine alone.", "population_specificity": "Patients with systemic lupus erythematosus (SLE) and associated co-morbidities like anti-phospholipid syndrome (APS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:45.961443+00:00"}
{"study_id": 76013, "supplement_id": 1364, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to review the available data on the use of N-Acetylcysteine (NAC) in various psychiatric disorders, assessing its potential as an adjunctive treatment.", "results_summary": "Promising results were found for NAC as an add-on treatment in cannabis use disorder, bipolar depression, schizophrenia's negative symptoms, and excoriation disorder, but efficacy in autism was disappointing. Further confirmation in larger, longer-term studies is needed.", "population_specificity": "Patients with psychiatric disorders, including substance use disorders, autism, obsessive-compulsive spectrum disorders, schizophrenia, depression, and bipolar disorder.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:47.195751+00:00"}
{"study_id": 76014, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of N-acetylcysteine as an otoprotective medication to reduce hearing loss caused by second-line injectable antituberculosis drugs in children with MDR-TB.", "results_summary": "The abstract mentions N-acetylcysteine as a potentially otoprotective medication but does not provide specific results regarding its effectiveness or safety in this context. The study highlights the need for further evaluation of strategies to mitigate adverse effects of injectables, including N-acetylcysteine.", "population_specificity": "Children treated for multidrug-resistant tuberculosis (MDR-TB).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:49.876800+00:00"}
{"study_id": 76015, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to model the pharmacokinetics of intravenous paracetamol and its metabolites, including N-Acetylcysteine, in neonates.", "results_summary": "The study characterized the pharmacokinetics of paracetamol and its metabolites, including N-Acetylcysteine, in neonates, noting small maturational changes in oxidation pathways relative to between-subject variability.", "population_specificity": "Neonates with a clinical indication for intravenous analgesia (mean gestational age 33.6 weeks).", "effective_dosage": "15 mg/kg doses of paracetamol at 12-h intervals (<28 weeks' gestation) or 8-h intervals (\u226528 weeks' gestation).", "study_duration": "72-hour study period.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:50.814752+00:00"}
{"study_id": 76017, "supplement_id": 1364, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the efficacy of N-Acetylcysteine in treating PTSD and substance use disorders (SUDs) when combined with cognitive-behavioral therapy.", "results_summary": "N-Acetylcysteine significantly improved PTSD symptoms, craving, and depression compared to placebo, though no significant differences were observed in substance use. The treatment was well-tolerated with high retention rates.", "population_specificity": "Veterans with PTSD and SUD per DSM-IV criteria (N = 35).", "effective_dosage": "2,400 mg/d", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:51.041717+00:00"}
{"study_id": 76010, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore whether cysteinet dysregulation contributes to muscular dystrophy pathogenesis and if N-acetylcysteine could restore this dysregulation.", "results_summary": "The study proposes that cysteinet dysregulation may underlie oxidative damage, calcium disturbances, and ubiquitin-proteasome dysfunction in muscular dystrophies, suggesting N-acetylcysteine could play a role in restoring this network.", "population_specificity": "Muscular dystrophy patients (theoretical, as this is a review paper).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:52.296396+00:00"}
{"study_id": 76018, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 67, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of N-Acetylcysteine (NAC) in preventing contrast-induced acute kidney injury (AKI) compared to other pharmacologic strategies and hydration alone.", "results_summary": "NAC alone showed a statistically significant reduction in contrast-induced AKI (OR 0.67, 95% credible interval 0.54-0.81). High-dose statin plus NAC was ranked among the best strategies for prevention, with an OR of 0.31 (0.14-0.60).", "population_specificity": "Patients undergoing diagnostic and/or interventional procedures requiring contrast media.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:52.313579+00:00"}
{"study_id": 76016, "supplement_id": 1364, "safety_score": "90", "efficacy_score": 60, "quality_score": 85, "study_goal": "The researchers aimed to determine whether N-Acetylcysteine (NAC) plus deferoxamine (DFX) reduces the incidence of acute kidney injury (AKI) in patients with shock.", "results_summary": "The study found that NAC plus DFX did not significantly reduce the incidence of AKI (67% placebo vs. 65% treatment group) but decreased the severity and duration of AKI and lowered serum creatinine levels at discharge, with no severe adverse events reported.", "population_specificity": "Critically ill patients with new-onset hypotension (mean arterial blood pressure <60 mmHg or requiring vasopressors).", "effective_dosage": "Loading dose of 50 mg/kg NAC over 4 hours, followed by 100 mg/kg/day for 48 hours; DFX was administered once at 1000 mg at 15 mg/kg/h.", "study_duration": "48 hours (after initial loading dose).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:52.665930+00:00"}
{"study_id": 76020, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 20, "study_goal": "The researchers discussed the potential of N-Acetylcysteine as a treatment option for progressive myoclonus epilepsies (PMEs), particularly for managing myoclonus.", "results_summary": "The abstract mentions N-Acetylcysteine as a potential drug for PMEs but provides no specific data on its efficacy, relying instead on anecdotal reports or small series. No conclusive results are presented.", "population_specificity": "Patients with progressive myoclonus epilepsies (PMEs).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:54.906165+00:00"}
{"study_id": 76019, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to compare the therapeutic effects of N-acetylcysteine (NAC) and Ukrain in reducing oxidative stress and pancreatic damage in rats with acute pancreatitis.", "results_summary": "NAC reduced oxidative stress markers (MDA, NO, TOS), inflammatory markers (TNF-\u03b1, MPO), and pancreatic enzymes (AST, ALT, amylase, lipase), while increasing antioxidant status (TAS). It also attenuated pancreatic damage, though the effect was less pronounced than with Ukrain.", "population_specificity": "Male Sprague Dawley rats with induced acute pancreatitis.", "effective_dosage": "Administered intraperitoneally 30 min and 12 h after AP induction (exact dosage not specified).", "study_duration": "24 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:55.858646+00:00"}
{"study_id": 76022, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to explore novel biological mechanisms in bipolar disorders, including oxidative stress, and evaluate emerging therapeutics like N-acetylcysteine.", "results_summary": "The abstract suggests N-acetylcysteine has potential as an antioxidant in bipolar disorder treatment, alongside other novel therapeutics, but specific efficacy data are not detailed.", "population_specificity": "Individuals with bipolar disorder (specific demographics not provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:57.966159+00:00"}
{"study_id": 76024, "supplement_id": 1364, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate preventive measures, including N-Acetylcysteine, against contrast-induced nephropathy (CIN) in patients undergoing endovascular treatments.", "results_summary": "The abstract mentions N-Acetylcysteine as one of the measures discussed for preventing CIN, but it does not provide specific results or conclusions about its effectiveness. The review notes that most available data on CIN are from non-surgical patients.", "population_specificity": "Patients undergoing endovascular surgical treatments, particularly those at risk of CIN.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:50:59.257099+00:00"}
